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Abstract 
There is an identified problem with patients receiving suboptimal pain management at a 
hospice agency in the northwestern United States. At this agency, undertreatment of pain 
is prevalent. Evidence indicates that this may be a result of a lack of guidelines, 
education, and knowledge of appropriate prescribing. Known barriers to the correct 
prescription and administration of potent opioids in the hospice setting include prevailing 
beliefs, knowledge, skills, and attitudes, all of which can impact care negatively. 
Contextually, hospice principles mandate patient comfort and caregiver involvement in 
continuous quality improvement, which includes adequate and informed pain 
management. Moreover, hospice metrics demand requisite knowledge, skills, and 
attitudes for optimal care, including pain management at the end of life. The Academic 
Center for Evidence-Based Practice (ACE) star model was used to guide the development 
of an evidence-based, guideline-supported educational program that will improve pain 
management at the hospice agency when implemented. The purpose of this project was to 
use transdisciplinary expertise and team collaboration to develop the program and then to 
conduct a formative and summative evaluation utilizing experts to prepare the guidelines 
and process for implementation. Ten experts reviewed the guideline, the educational 
materials, the process, and the evaluation plan and conducted reviews using the AGREE 
II tool. The panel of experts agreed within the 6 AGREE domains. Future implementation 
of this guideline, translation process, and evaluation tool will impact social change 
through the empowerment of the clinical staff, patients, and caregivers to provide the best 
pain control and comfort at end of life, a vulnerable time for all patients.   
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Section 1: Nature of the Project 
Context 
Hospice patients indicate a fear of pain. They need a regime of pain control that 
provides comfort, but there are issues with pain control in the hospice setting. This 
project was completed to address gaps in current knowledge about pain management and 
the limitations of prior studies. Researchers have highlighted considerable gaps in the 
availability of evidence-based pain management processes concerning discreet areas of 
practice such as hospice (Zaccagnini & White, 2011). There is a need for an Evidence-
based practice (EBP) Clinical practice guideline (CPG) for caregivers to standardize safe, 
effective prescription practices to improve pain management outcomes. Patient 
satisfaction data indicated evidence of unmet comfort expectations locally, regionally, 
and nationally. As a possible solution to the problem, I offered EBP guidance on the 
proper prescribing of opioids. Therefore, I have focused on developing a CPG for 
patients, families, and staff to resolve problems with inadequately controlled pain in 
hospice. The CPG may bolster positive social change efforts from a multidisciplinary 
team (MDT) collaboration approach to developing the EBP CPG. Implications for social 
change are in the context of data, consistent practice, education, and the need to 
disseminate transdisciplinary findings to benefit others. 
As researchers have noted problems with pain control for hospice patients, onsite 
the local Deyta surveys have exposed the same problem. A CPG development is a 
potential solution to widespread pain control issues. Therefore, my project was the 
development of an organizational pain management guideline for a local hospice. Later, 
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the hospice site may choose to implement the CPG, which I developed using sound 
scientific evidence. The CPG design will ensure patients receive appropriate pain 
management. Also, this CPG may potentially benefit other hospice locations regionally 
and nationally in addressing opioid prescribing problems. For this evidence-based, 
theory-supported CPG, I focused on safe, effective opioid prescribing for adult hospice 
patients and families. Guidance materials included an educational program and 
professional development processes. Gaps amid practical materials as meaningful EBP 
guidance for practitioners and resources availability were fully addressed after  the 
development of all the products. 
Project Sources of Evidence 
Hospice practitioners, healthcare providers (HCPs), and patients already know 
uncontrolled pain exists with end-of-life care (EOLC). To further justify this project, I 
reviewed the literature to identify specific sources of evidence in CINAHL, PubMed, 
Cochrane Review of Palliative care, and Hospice organization guidelines. To address the 
hospice agency’s challenge with pain control satisfaction, I developed consensus 
statements by synthesizing relevant findings from meta-analyses. The resultant 
recommendations translated as a CPG will intentionally optimize practitioners’ opioid 
prescribing. Dissemination of the hospice pain management CPG to the MDT and 
colleagues will potentially resolve pain control issues. 
Project Method 
Consistent with recommendations in the literature, I used a framework based on 
problem/patient/population/place, intervention/indicator/intended change, 
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comparison/current standard, outcome, and type of project—the (PICOT) model. This 
framework is relevant to practitioners to obtain hospice metrics for quality-of-life (QOL) 
and comfort. After developing the problem statement, I used the PICOT model to 
develop a strategic search of the literature for solutions.  
I completed a review of the literature to reveal possible sources of evidence for a 
CPG to benefit hospice care. I also reviewed expert consensus panels, as well as 
experimental and qualitative studies of meta-analyses that used randomized clinical trials 
(RCTs) as EBP hospice care evidence. Next, I applied the John Hopkins Levels of 
Evidence Hierarchy to grade, rate, and assess the quality (Seben, March, & Pugh, 2016) 
of the articles and used EBP methodology to classify the high-grade RCTs retrieved. An 
expert panel methodologically appraised the theory-supported CPG by using a previously 
established framework.  
After, gathering literature-driven solutions to develop the guidance, the panelists 
used the Appraisal of Guidelines for Research and Evaluation (AGREE II) framework to 
rigorously vet the guidance. Afterward, using proven EBP statements, I formed an EBP 
CPG to manage hospice pain. Practitioners at the site will be able to use this CPG as a 
source of accurate information on the best practices for prescribing opioids in EOLC for 
adults. Palliative care, opioids, and hospice were primary query terms. I chose the 
AGREE II instrumentation as the framework for the formative assessment of critical 
dimensions of the developed guidance.  
It was imperative to use the AGREE II framework as the principal evaluative tool 
to appraise the evidence applicability and gauge whether the evidence base ensures 
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guidance addressed the clinical state of hospice circumstances. Furthermore, the World 
Health Organization (WHO) Analgesic Ladder framework and Prochaska’s change 
model was conceptually relevant to understand the hospice philosophy of care. A Quality 
and Safety Education for Nurses (QSEN) consultant instructed the hospice guidance 
learners on how to obtain satisfactory mastery of pain management principles. The QSEN 
consultant integrated the ACE star model of knowledge translation to reinforce 
educational tasks with theoretical concepts to optimize opioid prescribing mastery. 
Project Pathway 
The purpose of this project was to address known gaps in pain management 
experienced by adult hospice patients. To achieve this goal, I developed a CPG, 
educational materials, an implementation process, and long-term evaluation planning 
based on theory and evidence. Through a formative and summative evaluation of the 
developed resources, an expert panel accepted a package of evidence. The evidence-
based, theory-supported pain management CPG resources I developed are for Northwest 
Hospice Center (NWHC) adult patients.  
Ultimately, a measurable, readily available CPG appeared to reach and exceed 
current standards. An onsite CPG positively affects safe pain outcomes for quality opioid 
prescribing in hospice EOLC. In a structured manner, this capstone project served as a 
platform to address a long-standing hospice issue and to offer EBP-proven solutions. The 
QI culminated in clinical guidance addressing possible gaps in knowledge and hospice 
practices. The agency’s mission, strategic vision, and hospice philosophy were 
fundamentally upheld as guidance resources became available to address practical gaps.  
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I presented a finalized product to the hospice organization’s MDT to implement 
as a trans-disciplinary approach. Thus, by design, the resources have applicability and 
transferability across all health care settings. The MDT of colleagues and stakeholders 
collaborated on major QI goals towards advancing EOLC. Transdisciplinary 
collaboration was imperative because inadequately managed pain and inappropriate 
opioid administration are urgent, critical social issues. Thus, the collaborative team 
initiative ultimately benefits society as stakeholders partook an effort to resolve a social 
issue. 
The CPG I have developed, and the ideas I applied in the process will advance 
society as a whole and therefore support Walden’s mission. The hospice’s organizational 
improvements from the project may help to address various pain and systemic societal 
issues. Hospice as a modern social movement seeks to change the individual experience 
of dying, as well as the nature of death and dying for society (Lander, 2017). Thus, the 
resultant EBP CPG aims to promote societal change on an organizational, regional, 
national, and global scale. 
Project introduction. In 2014, an estimated 1.6 to 1.7 million patients received 
hospice services (National Hospice and Palliative Care Organization [NHPCO], 2015b). 
Positive social change with pain management can manifest starting at the local facility, 
beginning with adequately serving the community’s families and individuals’ EOL pain 
control needs. The NWHC, the project location, provides services in various home-based 
settings within the local community. The goal of the capstone project was to inform 
providers of relevant, significant, innovative opioid prescribing for quality patient care. 
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Practitioners caring for terminally ill individuals in the northwestern United States are in 
dire need of an EBP CPG to address pain control. The CPG that I developed for safe, 
effective pain control provides caregivers practical guidance on relevant pain control 
concepts to achieve quality outcomes. Nationwide, the hospice community has grown 
substantially over the past decade in the number of hospice patients served (NHPCO, 
2015b); therefore, EBP materials are a necessity for hospice practitioners. 
Background. The growing EOL movement has spanned over two decades, and 
national attention is increasingly focused on QOL (NHPCO, 2015a). However, social 
factors continue to play a role in inadequately managed pain, affecting over 50% of older 
persons in communities (Hadjistavropoulos, 2012). However, researchers have long 
established that optimal pain control is a wish and preference of patients in the terminal 
phase of life (Stajduhar & Coward, 2012). With advances in science, QOL has improved 
across the life continuum, individuals have increased productivity in societies, and 
suffering is reduced (Zaccagnini & White, 2011). Hospice patients can require the 
prescription of strong pain relief, which only opioids may provide. Practitioners can 
resolve pain issues best with evidence-based, practical resources. Hence, with EOLC, 
there is a need for increased public awareness and practitioner education (NHPCO, 
2015a). 
In hospice care, there is an emphasis on dignity, comfort, and pain management. 
Hospice is a concept of care for those with a life-limiting illness no longer responding to 
curative measures. When the restoration of health is futile, an election of hospice care 
places a focus on the highest possible quality of remaining life and assuring comfort—a 
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hospice metric. Holistic care is given to the person and entire family to meet goals 
(NHPCO, 2015b). The hospice approach allows a natural, peaceful, dignified death with 
patients fully supported by families, friends, the medical community, and society in 
general (Thiroux & Krasemann, 2012). Patients and caregivers are at the center of the 
hospice team. 
At NWHC, patients’ needs are the care drivers. Thus, industry benchmarks and 
internal targets are used to monitor services related to comfort. Striving for comfort 
within 48 hours is a hospice metric. EOLC standards recognize comfort goals, and at the 
patient level, aim for quality improvement (QI). The NWHC site uses the Deyta Patient 
Survey (see Appendix B) hospice tool as it contains indicators to measure comfort, 
satisfaction, and QOL. As the Centers for Medicare & Medicaid Services (CMS) is a 
primary payer for reimbursement of hospice services, Deyta gathers, analyzes, and 
reports data as required per CMS regulations. Deyta offers benchmarking insight to 
hospice services for incorporating ongoing quality assurance performance improvements 
(QAPI). Amid “verbatim comment reporting” (Deyta, 2017) and patients’ admission 
statuses, NWHC monitors and tracks pain status measurements regarding comfort metrics 
and the negative patient feedback using the Deyta survey tool. As NWHC is not 
adequately meeting patients’ pain control needs, it is a feasible location to develop 
solutions for factors linked to the CPG uptake. 
Problem statement. The problem is a lack of EBP resources for practitioners, 
contributing to poorly managed pain in delivering EOLC services to adult hospice 
patients at NWHC. The Deyta survey documentation was the supportive evidence of the 
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pain issues. In the elderly patients over 50 years of age at NWHC, the survey 
documentation reinforced a dire need to improve pain control. At the hospice site, the 
unsatisfactory Deyta survey data alarmingly suggested opioid prescribing was 
problematic for practitioners and lead to patients’ poorly controlled pain.  
NWHC performed poorly during the first two-quarters of 2016 based on 
unsatisfactory figures with pain control. Deyta documentation contained disappointing 
feedback regarding pain management. Data documented from the survey revealed an 
emergent failure with quality control. Some of the areas of failure included pain 
management, continuous education on hospice metrics, and of ability to meet mandatory 
requirements as standards of care. 
In the pain management category, the Deyta survey indicator questionnaire 
revealed poorly managed pain, showing a 90% dissatisfaction rate with comfort. 
Regarding satisfaction with comfort obtained within 48 hours, 90% of clients expressed 
“No” when asked, “Was education provided on hospice medications?” The survey 
contained other pertinent yes/no questions in the Attend to Family Needs and Treatment 
of Symptoms categories (see Appendix B). An EBP CPG may improve metrics at the 
site. 
The preliminary Deyta documentation indicated hospice staff issues with opioid 
prescribing. Transcribed comments from the Deyta questionnaire showed a correlation 
between prescribing issues to patients’ dissatisfaction rates with comfort services. With 
evidently frequent problems with a pain control identified by significant dissatisfaction 
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pain management rates, the Patient, Intervention, Comparison, Outcome (PICO) 
framework applied to the project.  
The PICO that I formulated to facilitate a literature search for sources of evidence 
containing solutions to the hospice’s pain problem is as follows: 
P-Adult Hospice Patients 
I-Strong opioids as safe and effective treatments for pain control via guideline. 
C-Comparison of actual patient outcomes to the desired quality outcomes. 
O-Quality patient care as indicated by 100% patient satisfaction with comfort, 
pain control, and knowledge (Hospice metrics and hospice industry 
benchmarks). 
The hospice agency’s problem was caregivers’ lack of EBP resources, which had 
caused failures to maintain quality for comfort services. Due to the unavailability of EBP 
guidance, the organization was not providing these patients with optimal pain 
management. An EBP CPG was needed onsite to inform quality care. The EBP CPG was 
a necessary standard to achieve excellent pain control levels as desirable outcomes in the 
final phase of life. Therefore, resources needed to be available through an EBP program 
to assist practitioner prescribing at the local facility. The unmanaged pain problem and 
solutions are relevant to providers across disciplines aside from meaningfulness towards 
continuous quality improvement (CQI) in the local setting. 
Local relevance and practice environment. The Deyta survey feedback had local 
relevance regarding the improvement opportunity of a 90% dissatisfaction rate with 
comfort measures. At the very least, adverse Deyta data represented an unacceptable 
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short-term problem in maintaining the hospice philosophy of care. Thus, it is relevant 
poor pain control results are integrated and developed into resources to improve 
practitioner competencies regarding opioids. From the measures of caregiver satisfaction 
data identified, the opportunity to improve pain control lead to best practices for a 
reliable, expected standard of hospice care.  
Hospice is a model of quality care for individuals with life-limiting illness. 
Despite this, all too often, hospice patients risk receiving ineffective pain management 
(NHPCO, 2015a; WHO, 2014). This statement paralleled the organization’s problem. 
Currently, the survey highlights failures with providing training, education, and 
inaccessibility to necessary knowledge, skills, attitudes (KSA) competencies required 
with EOLC. As the current analysis of clinic data mirrored a national issue, the potential 
for suboptimal care was quite concerning. An opportunity was available to address this 
gap in practice with the availability of training materials. Quality comfort outcomes 
required a standardized method to educate caregivers on opioid drugs, as opioids are 
typically used as first-line in hospice to obtain patient comfort. The CPG contributed to 
better pain control at the agency by offering EBP pain management solutions on site for 
practical use. Practitioners needed a CPG focused on relevant research and implications 
with opioid prescribing in clinical practice. 
Significance and implications for nursing practice. Research has shown that the 
undertreatment of pain is a significant clinical problem (Bramadat, 2013). The significant 
implications and primary goals of hospice care are reaching quality measures and 
sensitive indicators nationally. A decrease in QOL is a sensitive indicator and is key in 
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determining the type of care received by patients (White & Dudley-Brown, 2012). The 
objective of EOLC is to maximize comfort for dying patients in the hospice setting. 
Patients desire minimal pain and no suffering from professionals entrusted (National 
Institutes of Health [NIH], 2015) with opioid prescribing to manage pain. Hospice 
practitioners are concerned with peaceful outcomes, hospice metrics, and standards of 
care for persons at the end-stage of life trajectory, and essential KSA competencies. 
KSAs aimed at sensitive quality indicators have a potential to close gaps in EOLC. 
The American Association of Colleges of Nursing (AACN) published “Peaceful 
Death” in which it outlined competencies as core curricula for providing quality EOLC 
(Workman, 2016). Current evidence-based knowledge on effective and safe prescribing 
of strong opioids using pain control principles holds clinical significance in EOLC. Thus, 
informing health care providers on pain management KSAs is an American Nurses 
Association (ANA) mandatory standard of care for caregivers and relevant to the 
practitioner’s education as a hospice metric. Teaching must consist of clarifying and 
resolving barriers to pain treatment, such as tolerance, fears related to addiction, a lack of 
awareness of regulatory compliance standards, management of side effects, opioid 
titration of doses (Hayes, 2013). 
Obtaining optimal pain control in a QI initiative within the DNP project is also 
significant because the ANA (2016) holds providers accountable to a high standard with 
pain management. Inadequate pain control may represent a neglect and failure to meet an 
obligation and denies fulfillment of a patient’s needs. Unrelieved pain has severe 
negative consequences on QOL (Bramadat, 2013). An MDT approach may promote the 
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delivery of quality care that facilitates optimal outcomes with prescription opioids. The 
CPG filled a gap in the literature regarding opioid prescribing and the implications for 
best practices. The effectiveness and safety aspects of the CPG were properly assessed 
and appraised for applicability to practice and evidence-based relevancy. 
Purpose statement. The goal of the project was to systematically develop a 
relevant CPG to help practitioners adequately manage pain and avoid outcome failures 
with opioid prescriptions. Specifically, the CPG was intended to help caregivers achieve 
quality patient care and satisfactory results with EOLC services. Additionally, an EBP 
CPG and educational effort for hospice professionals, patients, and families were focal 
points of the project. An expert panel formatively evaluated the CPG to help ensure that 
patients purposefully receive adequate pain control and comfort care at the local hospice. 
The CPG allowed frontline practitioners to prescribe opioids to patients effectively and 
safely.  
Subsequently the developed CPG I designed purposefully targeted hospice adults 
by incorporating patient feedback, educate individuals on KSAs with opioids, and 
emphasized MDT collaboration. Thus, with the CPG, positive outcomes with comfort 
were more likely at the local hospice site despite existing gaps in practice. The purpose of 
the CPG was to comprehensively address the prescription of opioids for pain control to 
achieve quality EOLC standards. Accommodating patients’ preferences for adequate pain 
control were purposefully fulfilled as the five critical domains of patient care within the 
CPG. In developing the CPG, I purposefully addressed the unavailability of scientific 
resources, which is recognized as a meaningful gap in practice. 
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Meaningful Gap-In-Practice 
The Joanna Briggs Institute publicly emphasized that there should be more 
resources available in hospice practice. The Briggs Institute has publicized that it favors 
initiatives that produce hospice-specific guidance to account for gaps in resources and 
practice. An obstacle contributing to the hospice agency’s problem with controlling pain 
is that caregivers lacked a CPG that informed them of quality EOLC. EBP resources had 
to be accessible to achieve the desirable outcomes of excellent pain control levels in the 
final phase of life. The EBP CPG materials intervened with competency teachings on 
KSAs to meet expected quality pain management outcomes once implemented.  
At the hospice site, meaningful gaps lie between the ideal and reality. Gaps 
existed in what practitioners actually were doing and what really should be performed 
when prescribing patients opioids. The project bridged the gaps in EBP practice resources 
and knowledge. An educational program for clinicians, patients, and families will address 
potential barriers learners may encounter with implementing the CPG. The educational 
guidance resources developed clarified concepts, resolved learners’ obstacles, and 
countered barriers to adequate pain treatment. The training materials bridged the learning 
gaps on associated pain concepts such as: addressing fears related to addiction, tolerance, 
awareness to regulatory compliance standards, management of opioid side effects, and 
titration of opioid doses prescribed (Hayes, 2013). 
As a practical resource, the EBP CPG activities counteracted identified barriers 
and gaps by intervening with teaching KSA competencies and appropriate prescribing. 
The Agency for Healthcare Research and Quality (AHRQ) National Guideline 
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Clearinghouse (NGC; 2016) was useful in developing the quality CPG. Upon 
implementation of the EBP CPG for pain management, AHRQ resources help assured 
expected quality outcomes. The guidance serendipitously covered national pain 
management issues as well. The CPG applicability was due to the transparency of 
resources, rigorous EBP processes, and resolute activities to develop the agency’s 
guidance. 
PICOT Question 
The DNP project question is as follows: How would the development of an EBP 
CPG with professional education influence the pain management practices to improve 
pain control for patients in an EOLC program at a hospice center? 
The PICOT question elements were: 
P – Problem / Patient / Population / Place: Patients at the end-of-life, self-reported 
poor pain control, home care program provided by a hospice center. 
I – Intervention / Indicator / Intended change: Evidence-based clinical practice 
guideline with staff education. 
C – Comparison / Current standard: Pain management without a clinical practice 
guideline. 
O – Outcome desired: Decreased patient-reported pain and increased patient 
satisfaction.   
T – Type of project: Clinical practice guideline development with professional 
education for the implementation. 
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The optional T in PICOT was useful to help with the determination as to the type 
of project I would pursue for the question I sought to answer. 
Project Objectives 
The guiding practice-focused question is the following: Does evidence support the 
development of an EBP CPG that addresses patients’ pain management in a hospice 
program? To solve hospice pain control issues, I focused the project on developing an 
EBP CPG with a professional education program for practitioners, patients, and families. 
The guidance addressed identified gaps in scientific knowledge. KSAs and a QI effort 
aiming for excellence offer a tremendous measure of retainable comfort with EOLC. 
Once practically implemented, the specific aim of the EBP CPG helped caregivers 
achieve quality standards for pain control in EOLC. The project objectives ensured that 
patients at the local hospice received adequate pain control and comfort care.  
The aims and objectives of the Capstone QI project were as follows: 
1. Develop an EBP CPG from sources of evidence accepted through a formal 
review by expert panel members. 
2. Present EBP educational materials for formative evaluation and acceptance by 
an expert panel. 
3. Obtain approval of an EBP implementation process constructed for formal 
evaluation that is also accepted by expert reviewers.  
4. Establish a long-term evaluation plan based on theory and evidence to meet 
goals such as the following:  
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a. Reduce response time for pain control to less than 48 hours when 
ordering pain medications for 100% of patients with pain greater than 
3 (on the 0–10 Wong-Baker pain scale) (Wong-Baker Faces, 2016). 
b. Increase completion of caregiver education training modules to 100% 
participation in at least 90% of the training sessions, two of which 
must be the first and last sessions. 
c. Increase the percentage of satisfactory responses measured by the 
Deyta Patient Survey from 10% to 90% over a 6-month duration, with 
a goal of 100% within a year. 
5. Acquire acceptance of the entire package of evidence from expert reviewers 
through a formative and summative evaluation. 
CPG Objectives 
1) Establish an evidence-based universal CPG for hospice practitioners. 
2) Consider resolutions to potential barriers to developing the CPG, such as time, 
staff skill, adoption, resources, the organization’s interest, translation, and 
dissemination.  
3) Perform a windshield survey to appraise the hospice community’s resources. 
4) Utilize a Gantt chart to meet objective deadlines and assist in developing CPG 
activities.  
5)  Address the significance of including representatives from the target 
population with stakeholders involved in the planning process. 
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6) Involve providers, families, and patients directly in developing the CPG to 
overcome barriers and enhance patient satisfaction with pain control care. 
7) Consider costs, acquisition, and social aspects of an under-served hospice 
population concerning the opioid class of drugs with developing the CPG. 
8) Develop processes based on scientific literature to educate providers on the 
CPG. 
9) Incorporate practitioners ability to demonstrate cultural competency related to 
pain and pain management addressed through professional development 
training. 
10) Implement educational planning and offerings using EBP sources such as the 
EOL Nursing Education Consortium (ELNEC) and QSEN to link meaningful 
constructs with developing the CPG for adult hospice patients. 
11) Use the ACE star model to link relevant theoretical concepts to the CPG. 
12) Use the EBP “FOCUS” strategy to guide the hospice practice adhering to 
regulatory standards set forth as TJC goals for quality care to develop the 
CPG. 
13) Use TJC’s pain issuance standards on safety, quality, and the hospice patient’s 
right to pain management when developing effective pain control guidance. 
14) Refer to AHRQ QI initiatives to aid and develop a standardized institutional 
educational guideline  
15) Align the CPG with Medicare hospice COPS established regulations. 
16) Include ANA standards in the CPG QI effort for correct opioid prescribing.  
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17) Consult the NHPCO in the furtherance of the CPG for practitioners and 
feedback from the MDT of colleagues.  
18) Address associated pain concepts with the CPG developed. 
19) Comprehensively cover alternative opioids prescribing methods to manage 
pain. 
Response to the gap-in-practice. Guidance developed for better pain 
management centered on improving EOLC and expanding hospice knowledge towards a 
goal of the same. At the home-based hospice facility, there were identifiable factors 
related to prescription opioids, pain management, education, and limited resources. EBP 
knowledge was necessary to reduce gaps in resources as well as enhance KSAs. HCPs 
must have an attitude of respect and awareness and be skilled at handling sensitive issues 
(Hayes, 2013).  
The DNP project was a platform to present guidance for a peer review of an EBP 
CPG that offered caregivers attitudes of reassurance with opioid prescribing. The entire 
agency benefited when guidance on current best practices for prescribing was available. 
NHPCO is a non-profit, national organization for hospice programs and professionals 
(NHPCO, 2015b). Thus, NHPCO resources guided collaborative interdisciplinary team 
(IDT) efforts. KSAs aimed at sensitive quality indicators have the potential to close gaps 
in EOLC. 
Stakeholder analysis. Stakeholders from relevant professional disciplines had 
representation through the MDT with developing the CPG. The CPG appraisal required a 
formal panel of expert reviewers. The expert panel of stakeholders was the necessary 
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convenience sample of participants required for sufficient resources to develop the CPG. 
The professional colleagues, group process leaders, and IDT and MDT members 
contributed to developed materials with a wide range of skills as clinical health services 
researchers. These groups of stakeholders formed the formal committee to offer 
interdisciplinary feedback on the CPG. 
Confidence with participatory feedback has potential impacts such as fear of 
retribution from senior administrative management. Obstacles may occur as stakeholders 
express perceptions and understandings of pain control. Diversity barriers concerning 
pain management may be a hindrance because individuals differ considerably on opioid 
and pain issues. However, barriers may be overcome by just agreeing to what it is known 
and proven in the evidence. It is known that individual pain experiences are highly 
subjective. In EOLC, the IDT has stated that a hospice patient’s report of pain is the only 
confirmation required for its (pain) existence. In the latter phases of guidance 
development, sources of evidence were sought to validate the best pain control 
approaches to resolve stakeholders’ opposing views.  
 The final product from the project served to educate the organization’s 
stakeholders. The CPG informed providers, caregivers, and patients alike on opioid 
prescribing for comfort measures. Within the hospice specialty, there are routine 
concerns about available up-to-date resources. There is an overall need for EBP data that 
enhances care. A purposeful CPG was established to benefit all stakeholders and patients 
alike. Terminally ill patients benefited in the form of safe, effective, and quality EOLC. 
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Potential contributions to nursing practice. The CPG contributed to the unique 
practice of caring with marked impacts by allowing full expression of the hospice role to 
fill systemic gaps in resources needed in EOLC. Establishing this hospice guidance 
contributed to improvements in hospice practices that has versatility that may be modeled 
in all settings. Pain control materials contributed to evidence-based nursing practice 
(EBNP) through a problem-solving design. A conceptual analysis of EOLC contributed 
to nursing practice from a component of the CPG, the inquiry of understanding the 
hospice philosophy of care. The CPG provided essential knowledge of opioid 
prescription practices to hospice practitioners. With particular concern for opioid 
prescription factors affecting hospice, solutions from broader realms of scientific and 
theoretical thought contributed to the body of nursing knowledge. By offering evidence-
supported pain control guidance, overall, the CPG contributed to nursing by connecting 
theory and practice. The contribution of EBP scholarship and body of knowledge for 
forming prescribing guidance was so necessary for practice and transdisciplinary growth. 
Transferability of knowledge. The CPG design contributed to improved comfort 
outcomes beyond the local hospice site in many ways. The local agency had an IDT to 
represent numerous disciplines with several professionals involved in the patient care. 
This diverse hospice staff had physicians, hospice home health aides, social workers, 
chaplains, physical therapists, occupational therapists, speech-language pathologists 
(SLP), registered dietitians, registered nurses, nurse practitioners, and nurse case 
managers involved in the care of patients and families. The hospice IDT offered a wide 
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range of services from a holistic approach, and therefore, feedback was applicable on a 
transdisciplinary platform. 
Inclusive gathering of significant data from the IDT enabled implementation of 
culturally congruent care across several disciplines. Cultural pain may occur when 
providers overlook patients valued way of life. The MDT will overcome barriers 
associated with views of pain problems. Comprehensive IDT input positively influenced 
systemic pain barriers related to beliefs, practices, and values. The MDT holistically 
contributed to developing the pain control guidance through multidisciplinary input that 
informed value care. The motivation of the IDT was crucial to the success of developing 
the CPG for individuals, families, and communities. 
Engaging various fields in a collaborative QI effort increased transferability of the 
CPG for prescribing opioids beyond hospice practice. Knowledge may transfer across 
disciplines to MDTs as a result of the various professionals of the IDT who consulted on 
pain control barriers and social inequities with EOLC. Unmanaged pain is a critical social 
issue. Myths may be commonly magnified when related to opioid prescribing in hospice 
settings, further contributing to social problems. The social barriers with opioid 
prescribing served as an incentive for me to achieve major QI goals. I ultimately assumed 
a transdisciplinary approach to advance EOLC for the greater good of society. 
Implications for Positive Social Change 
Across disciplines and healthcare settings, in general, pain is undertreated for 
various social reasons. It is also widely known opioid prescribing affects communities 
nationwide. At the hospice, patient comfort was a high priority and social responsibility. 
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The impetus for social change was advocacy and socio-political justice for a vulnerable 
hospice population. Practitioners are to question reasons pain control issues exist and be 
willing to scrutinize practices for clinical proficiency. Society’s inquisitive conversations 
about life and a dignified death are defining moments representing the modern hospice 
movement. Modernized protocols with EBP resonated with practitioners as the developed 
CPG informed appropriate opioid prescription practices for pain control. 
The project supported Walden mission by offering expert knowledge based on 
sound scientific research. This project was an opportunity to promote practitioner use of 
academic knowledge to effect positive social change through research. As a contribution 
to society, the project positively impacted EOLC for patients within the hospice 
community and beyond. As hospice patients face social disparities, the data and 
disseminated findings impacted social change by broadly informing healthcare decisions, 
EOLC practices, and social justice policy. 
The CPG on pain management addressed positive social change because, as 
sociologist Anthony Oberschall (2017) argued, with social change, there must be an 
organizational basis. Resolving this hospice issue of patient dissatisfaction at the hospice 
organization in the local community contributed to fixing aspects of the broader social 
problem with comfort care. This project allowed a potential for NPs to influence societal 
changes that may occur locally and progress at the regional, national, international levels.  
Summary 
Pain is not well managed nationally as evidenced by the Joanna Briggs Institute, 
which cites major gaps between available resources and actual practice. Locally, there 
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had been a longstanding issue with quality EOLC, concerning adequate comfort measures 
for hospice patients. As topics on opioids are scrutinized more heavily now than ever 
(National Institutes of Health, 2015), efficient prescription solutions to mitigate pain in 
EOLC was a pertinent issue to address. Improperly managed pain is significant as major 
gaps in EOLC necessitate urgent attention from multiple stakeholders. 
 At NWHC, an identified problem was insufficient pain control for hospice 
patients. Resource availability was clearly a prime factor in the agency’s pain 
management problems. Frontline providers lack the KSA resources required for sufficient 
pain control. The absence of resources was an obstacle to the satisfactory 
accomplishment of patients’ comfort goals at NWHC. As the pain control problem 
hindered the achievement of goals uniquely established by hospice patients, solutions 
were relevant to the profession and HCP across disciplines. 
 An initiative needed to be undertaken to offer guidance purposefully. An EBP 
CPG was a meaningful solution intended to help the facility’s practitioners best manage 
pain. The QI project purposefully centered on hospice metrics to develop a guideline for 
appropriate, safe, and efficient prescription of opioids as a standard of care. The 
overarching aim of the QI project was to produce an EBP CPG that significantly reduces 
adverse pain experienced by hospice patients.  
Goals of the project were to overcome barriers with EOLC competencies and 
potentially contribute to narrowing gaps in practice. Quality EOLC is meaningful in the 
context of federal regulations, local mandates, and agency protocols. The EBP CPG 
standardized pain control practices across the board for consistency with opioid 
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prescribing in EOLC. This contribution of new knowledge does not only relate to the 
hospice care field. The manner in which I designed the guidance transfers outside of 
hospice and is applicable in all healthcare settings. Awareness of EBP at the hospice site 
with a CPG also has exponential benefits that transfer across multidisciplinary specialties. 
Transferability of the guidance was necessary as social issues with opioid 
prescription and pain management are well documented. The collaborative team of 
hospice experts and professionals formally engaged in feedback to produce evidence-
based practical solutions. As perceptions about EOLC may vary considerably across 
culture, educational backgrounds, and status, etc., there are societal gains by offsetting 
costly regimens from incorrect or insufficient data on EOLC. 
The EBP CPG I developed significantly improved KSAs and aimed for 
therapeutic patient outcomes by removing prescribing barriers to advance EOLC. Also, 
the guidance produced resulted in a standardized guideline. The purpose of the CPG was 
optimal comfort from the best methods relevant to prescribing opioids. The developed 
hospice materials on correctly prescribing opioids easily cross over to benefit other 
disciplines and societal change. 
To best effect social change with the CPG, it was appropriate to analyze multiple 
sources of evidence as literature solutions. Literature-driven recommendations are the 
most appropriate sources to consult for EBP on proper opioid prescribing. Using 
solutions I retrieved from the literature; I developed consensus statements into an EBP 
CPG on pain control for adult patients. The CPG was to target hospice patients receiving 
EOLC in community settings. Since outcomes of the CPG affects various populations, 
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settings, and disciplines, a systematic review of the literature underpinned the guidance 
recommendations. Thus, I consulted studies from other professions—medicine, 
psychology, gerontology, and social work—to develop EBP guidance. Exclusion criteria 
included several systemic analysis publications of articles unavailable in the English 
language. Exclusion criteria also mattered when searching for current, accurate, and 
general articles in a scoping review of the literature. 
Performing a scoped literature review was to obtain the highest level of evidence 
for appropriately managing pain with hospice adults. I needed to center the project on 
sound quality evidence. I used the scientific literature as sources for data about the issue 
of inadequate pain control for terminally ill individuals. Thus, I consulted multiple 
scholarly databases in a search for high-level systemic reviews for appropriate measures 
to address aspects of opioid prescription. 
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Section 2: Background and Context 
Introduction 
At NWHC, I identified the practice problem of inadequate pain management, 
primarily due to lack of EBP materials. In the absence of an available protocol addressing 
a consistent method for prescribing safe and effective opioids, an EBP CPG needed to be 
established. For the developed PICO question, I conducted a literature search for methods 
to apply outcomes for safe, effective opioid prescription solutions. These solutions 
needed to align with this practice-focused question developed from the PICO (T) process: 
How will a developed EB-CPG affect hospice patient reports of discomfort to 
control pain for adults receiving EOLC? 
The PICO query addressed the availability of EBP resources for pain problems 
due to gaps in proper opioid prescribing and adequate pain relief for hospice patients. The 
purpose of the project was to develop an EB-CPG to standardize practitioners’ 
prescription of opioids for elderly hospice patients. The CPG was intended to improve 
IDT and MDTs’ prescribing competencies in addition to effecting social change. The 
CPG I developed presented the best manner to control pain with strong opioids. After the 
CPG acceptance, I developed educational materials. Training was intended to provide an 
evidence-based process for frontline practitioners’ adoption of guidance, materials, and 
resources. 
The literature review aimed to retrieve published evidence that systematically 
answered the PICO question. The PICO answer served as a part of the solution to the 
problem and as a primary tool for developing the CPG. I conducted a meta-analysis of 
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scientific evidence from meta-analyses and systemic reviews primarily to develop the 
CPG, materials, and processes for quality EOLC. In developing the EBP CPG, methods, 
and materials, I searched the literature indexes for scholarly theories, EBP concepts, and 
models. 
Concepts and Models 
Ample research supported the PICO (T) model. The PICO framework helped with 
the formulation of quality hospice objectives. The PICO format yielded relevant 
concepts, hospice metrics, and QOL outcomes beneficial to practitioners. I searched the 
literature systematically to locate sources of EBP for hospice care. To grade the peer-
reviewed research literature that informed best practices for the hospice guidance 
produced, I selected the Johns Hopkins EBP model and applied it to rank evidence levels 
from I to level V. These levels, according to Seben, March, and Pugh (2016) are as 
follows:  
 Level I: Meta-analysis of RCTs; experimental studies; RCTs.  
 Level II: Quasi-experimental studies. 
 Level III: Non-experimental or qualitative studies. 
 Level IV: Opinions of nationally recognized experts based on research 
evidence or an expert consensus panel. 
 Level V: Opinions of individual experts based on non-research evidence (e.g., 
case studies, literature reviews, organizational or personal experiences).  
Using the John Hopkins EBP model, I found five Level I, one Level II, two Level 
III, two Level IV, and five Level V sources. 
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Quality hospice care is multifaceted. It encompasses five domains of patient care 
(Stajduhar & Coward, 2012): physical, functional, spiritual, psychological, and social. It 
includes not only patients but their families as well. As defining features of a practitioner 
approach to hospice care as well as support for the principles and philosophy of hospice 
care, the CPG guidance reflected dimensions of the Quality-of-Life model.  
As the CPG was evidence-based, I needed a sound tool to appraise it. Within the 
scholarly databases, numerous researchers recommended AGREE II. I, therefore, 
selected AGREE II as the principal tool to assess crucial dimensions of the guidance to 
ensure that it thoroughly addressed the current clinical state of hospice circumstances. In 
also, following the recommendations in the literature, I selected the ACE model to 
integrate educational tasks involving EBP theoretical concepts with opioid prescription 
practices. 
Conceptually, an ELNEC consultant helped learners master pain management 
principles using QSEN reinforcement, Prochaska’s Change Model in piloting, and the 
WHO analgesic ladder. In the general literature search, I retrieved A Comparison of the 
WHO Model List of Essential Medicines and the Lothian Joint Formulary scholarship 
provided by the National Health Service (NHS) Lothian (WHO, 2017). 
Theories and Seminal Scholars 
Patricia Benner, a seminal scholar who devoted much of her professional life to 
studying nursing issues, revealed theory-based solutions (Chan, Benner, & Brykczynski, 
2010). Benner’s novice to expert theory related teaching KSAs, QI educational 
initiatives, and the doctoral capstone methodology to innovative nursing pedagogy. The 
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Dreyfus model of skill acquisition (McEwen & Willis, 2011) added value to evaluating 
caregiver knowledge acquired, to narrow gaps between practice and experience. 
Researchers plentifully noted clinical decision making (CDM). 
However, I chose AGREE II as the appraisal tool to help the expert panel evaluate 
my developed protocol. The CPG that I derived from AIM statements based on the 
literature review targeted hospice patients along the EOLC trajectory. The AIM 
statements helped ensure that protocols developed for practitioners covered AGREE II 
domains in the appraisal phase. Supported by evidence from the literature, the AIM 
statements targeted areas of improvements for an adequate opioid prescription. Findings 
from the literature review served as quality indicators and centered on monitoring the 
effectiveness of services. The AIM statements allowed components of the CPG to 
develop theoretically and conceptually relevantly. 
Definition of Conceptual Terms 
Analgesic: A medication that may relieve pain, for example, opioids like 
Morphine, Codeine, or Oxycodone (Venes & Taber, 2013). 
Analgesic ladder: The WHO framework for treating pain, where the patient is 
treated first with anti-inflammatory analgesics, such as ibuprofen, or mild or non-narcotic 
pain relievers, such as acetaminophen. A patient may be ultimately treated for pain with 
increasing strengths of narcotic analgesics if anti-inflammatory drugs or adjunctive 
therapies do not alleviate pain (Venes & Taber, 2013).  
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Caregiver: An individual assisting a (terminally) ill person in an environment the 
individual resides. For the purpose of this manuscript, the term carer also refers to 
individuals involved with the patient’s care. 
End-of-life (EOL): The end of a normal life cycle. It is a phase on the continuum 
of care, the end-stage, the final phase of a disease process (Stajduhar & Coward, 2012) an 
acceptable death, also known as a good death imminent. 
EOL (hospice) care (EOLC): defined by adequate pain control, minimal suffering, 
and the absence of trauma, which leads to peaceful deaths. The IOM has undertaken 
major initiatives towards outcomes facilitating a good death to improve EOLC 
(Workman, 2016). 
Hospice: Both a system and philosophy of care. It is a program (WordPress, 
2011) that specializes in care in which attention is given to fulfilling the needs of patients 
with a limited life expectancy at the EOL. Hospice focuses on comfort rather than cure. 
One of the main goals of hospice care is helping patients live comfortably and to help the 
family support the patient as they are transitioning with outcomes to facilitate QOL and a 
peaceful death. An IOM report offers three definitions, first described as a discrete site of 
care. Secondly, hospice is an organization that provides and arranges for services to 
patients in homes or other settings. Thirdly, hospice is an approach to care for dying 
patients based on metaphysical, spiritual, social, and clinical, social, and principles 
(NCHPC, 2014). The principles of hospice include providing care to a whole person 
along with the entire family, placing the patient and caregiver at the center of the hospice 
team, educating, and providing comfort when cure is no longer possible for terminal 
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illnesses (Workman, 2016). IDT members provide regular visits for care and assess for 
additional service needs. Hospice staffs are on call 24 hours a day annually. 
Pain: As the International Association for the Study of Pain (IASP; 2015), defines 
it as an unpleasant emotional and sensory experience arising from potential or actual 
tissue damage; it not only is a perception of painful stimuli, but also a response to it. The 
hospice approach recognizes that pain is a complex phenomenon that involves the mental 
or emotional, the social or sociological, and the spiritual or religious aspects of patients as 
well as the physical (Thiroux & Krasemann, 2012). 
Pain control: Comfort defines pain control. Comfort is relief obtained from the 
administration of treatment strategies and other interventions to manage discomfort. At 
the hospice site, the patients determine an acceptable level as their pain goal. Pain control 
and obtaining comfort are defining features of the hospice philosophy of care with 
principles to maintain QOL (Thiroux & Krasemann, 2012). Once pain is seen for what it 
is, a preventive rather than a reactive approach to pain control should be used. For 
example, once a terminal cancer patient begins to suffer pain, the method of pain control 
should not be to wait until the moment the pain returns, thus “reacting” to the pain 
symptoms (Thiroux & Krasemann, 2012); rather, the patient’s pain should be prevented 
from occurring. 
Terminal illness: A life-limiting medical condition, a final, fatal illness, in which 
a person has been certified to have a life expectancy of fewer than six months. 
Project relevance to nursing practice: broader issues and scholarship. The 
Capstone had relevance to inform practice, EOLC, healthcare policy, and society. In 
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2015, 35% of Americans were prescribed opioids (American Association of Nurse 
Practitioners [AANP], 2017). The profession has ethical, professional, and social 
responsibilities to remain informed on issues of correctly prescribing opioids. Therefore, 
it was relevant practitioners receive KSA education for safe, effective prescribing of 
opioids as EBP guidance. The EBP CPG addressed a need for available resources for the 
organization, public, and profession.  
As an overall societal problem existing with quality EOLC (NHPCO, 2015a), the 
local measures of patient dissatisfaction with pain control coincided with widespread 
issues. Awareness must be provided concerning solutions to pain management issues. 
Awareness in practice on opioid prescribing was necessary concerning society, 
legislation, regulations, and policy that affect EOLC. ACE was the model to guide 
educational offerings and evaluation of learning. There is a local and national need to 
satisfy hospice patients with therapeutic pain relief services concerning the broader 
practice problem in which the QI project is embedded. 
Scholarship on broader issues. Speaking to the broader issue, scholarship by Hall 
(2013) read knowledge, experience, and expertise should be gained with opioids and after 
that, prescribe strong opioids where possible. Forbes (2016) said more data and KSAs are 
required to counter myths or beliefs held on opioids in society. Nationally, the overall 
management of pain does not meet quality standards (Institute of Medicine of the 
National Academies [IOM], 2012). As global pain management issues are hindering 
quality comfort measures (Brennan & Bakken, 2015), currently, there is a need for 
standardized, informed opioid prescribing (Bramadat, 2013). 
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Current state of practice and recommendations. A current awareness to pain 
control problems existed in ample theoretical sources. Most studies highlighted 
knowledge and skills are continually lacking or not present concerning EOL, pain, and 
prescription analgesics (Al-Shaer, Hill, & Anderson, 2011). Articles noted there are still 
persistent misconceptions related to opioid use, addiction fears, and frequent 
underestimations of pain and interventions tailored to meet learner needs (Al-Shaer, Hill, 
& Anderson, 2011). Others studies placed a current pain control focus on changing 
hospice patients and caregiver’s KSAs as cited by Al-Shaer, Hill, and Anderson (2011). 
Unmanaged pain concerns in EOLC are known nationally. With the facts 
concerning problematic, inadequate opioid prescribing to sufficiently control pain at the 
local setting highlighted, an issue significant to a broader field beyond hospice practice 
existed. Nationally, there is a need to develop more up-to-date educational opportunities 
and clinical pathways.  
Recommended current practice improvements. More current CPGs were 
needed and recommended for QI in EOLC with opioid prescribing. Moynihan (2015) 
advises combining nonpharmacological strategies with analgesics. Additionally, 
scholarly sources indicative of the current state of issues strongly advised adjunct 
therapies for pain management in hospice. Two level I articles by Chang, Bijur, Lupow, 
and Gallagher (2011; 2013) asserted approaches to uncontrolled pain variability requires 
frequent dosing of prescription opioids, with adjuvant analgesics such as antiepileptic 
drugs, antidepressants, and local anesthetics enhance care. 
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The John Hopkins model classified the current findings, as AGREE II appraisal 
validates guidance resultant of the evidence findings. The National Institute for Health 
and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN) 
has developed a suite of quality standards based on high-quality guidance (SIGN, 2014). 
The NICE accreditation program aimed to raise the quality of data used by health care 
professionals by evaluating the processes used by organizations to produce guidance and 
recognize those that meet a set of criteria (SIGN, 2014). Thus, the criteria were based on 
the AGREE II instrument. The AGREE II tool was most suitable out of tools reviewed, 
based on the applicability of standards, credibility, and international recognition. 
It was unequivocally stated requisite pharmacokinetics, equianalgesic dosing, and 
adverse effects awareness on wide-range of issues is necessary, a Prommer and Picek 
(2012) study asserted. The utilization of multiple EBP strategies was warranted to tackle 
broader issues of competency and practice gaps (Zaccagnini & White, 2011). The 
Scoping review of the literature was especially focused on EBP, CPGs, and education. 
Credible articles were sought for instances where opioid responsiveness is questionable 
in the care of adult hospice patients. Others have approached pain control issues using 
alternative nonpharmacological strategies to alleviate pain from various etiologies 
(Gaertner, Siemens, Antes, Meerpohl, Xander, Schwarzer, Becker, 2015). The Scoping 
literature review consisted of general and specific strategies.  
Search Strategy for Sources of Evidence-The Literature Review 
A scoping literature review conducted was a non-exhaustive comprehensive 
systematic query. The PICO (T) question guided the scoping literature review in a 
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systematic direction. Exclusive and inclusive criteria were applied to yield a final list of 
articles. From these articles, EBP data were extracted, selected, and saved into a literature 
review chart. This literature review consisted of an electronic search was conducted using 
selected keywords on some of the main databases on health science, selected websites, 
and a focus on primary reference books for learning organizations and EBP. The search 
for sources was restricted to English language articles only. 
Specific Literature Review Search Strategy 
In the scoping literature review based on specific methodology, sources of 
evidence were sought using queries of MEDLINE (from 2000 to 2017). Also, CINAHL 
(from 2000 to 2017) was queried to review and identify intervention studies aimed at 
increasing patient and caregiver knowledge to change pain management behaviors. 
The search narrowed down during a period of 2011 to 2017 to obtain specific 
search results with palliative care, hospice, and opioids to gain a better view of 
documents for what was known about hospice pain experiences and its relatedness to 
practitioners. Major emerging themes were: provider knowledge (mentioned several 
times), educating (mentioned several times), fear (mentioned several times), need for 
pedagogical discourse (mentioned several times), and a need for opioids (mentioned 
several times). 
A list of these key wording created the terminologies used to perform the specific 
literature search. Keywords searching returned dozens of relevant articles about the 
opioids and hospice care. For this project, 15 relevant studies were selected based on the 
search terms: opioids, pain management, hospice intervention, and education. In a few 
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articles, it was evident data and lengths were condensed, perhaps as sections were cut to 
meet requirements for publication. However, compared to other practice specialties, an 
overall literature review seemed sufficient with typical limitations in the numbers of 
research conducted on EOLC. 
Gathering and analyzing credible studies from databases was germane particularly 
when ample consideration was to locate interventions reflects EBP (Polit & Beck, 2012).  
Critically assessing the hierarchy of evidence from the literature base was equally vital. 
The broader article searches became; quantity prevailed over quality. In reviewing the 
relevant scholarship, the advice is to consider quality over quantity. Quality is all too 
important in EBNP. Quality articles on pain management and opioid prescribing were 
obtainable from the Scoping literature review strategies.  
General Literature Review Search Strategy 
In a general literature review, CINAHL was primarily the database used. 
ProQuest, PubMed, Nursing Academic Search Premier, Allied Health Source, and 
Google Scholar also was searched for articles. In one strategy, a review of reference lists 
of publications identified in my specific literature searches located even more studies. 
Hospice educating for palliative care of pain with opioids at the EOL was the most 
general area of focus. Search engines and Boolean operators allowed terms and word 
combinations to be queried. Truncation populated broadened the queries by automatically 
searching for variations of terms entered.  
I made queries using the following search terms: hospice, life care the home, end 
of life, nursing, community nursing, hospice nursing, terminal illness, terminal care, 
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comfort care, end-of-life care, hospice care, definitions of pain, pain experience, pain 
and self-knowing pain, pain pathways, pain clinics, pain and teaching patients, health 
disparities, palliative medicine, end-stage palliative treatments, palliative care, ethical 
care, ethical hospice care, ethical end of life care, health policy, qualitative methodology, 
model, theory, pain and guidelines, actively dying and narcotics, hospice and analgesic, 
hyperalgesia and opioids , caregivers, pain and nursing education, and practitioners and 
opioids.  
Strategies and Standard Practices Previously Used to Address Gaps in Practice 
An outcomes research was reviewed to examine the results of care by Rudy, Daly, 
Douglas, Song, and Dyer (as cited in Grove, Burns, & Gray, 2013) to look at pain 
outcomes in the chronically critically ill special care unit. A study by Rasmussen and Farr 
(as cited in Grove, Burns, & Gray, 2013) examined pain problems and EBNP research, to 
identify areas of concern that require investigation to general insights to expand 
understandings of pain comprehension holistically. 
Fenwick, Chaboyer, and St. John (2012) performed grounded theory research for 
decision-making processes used by persons to manage persistent pain; finding that 
persistent pain resulted in disruption of the known self. Self-management was identified 
as an overall transforming of the deciding self in three sub-processes: identifying 
consequences, actions, and conditions influencing self-disruption of sub-processes 
(Fenwick et. al, 2012). Fagerhaugh and Strauss (2015) developed a pain management 
theory identifying the following relationship: As expressions increase, pain management 
increases; the proposition was developed using grounded theory research.  
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The Fagerhaugh and Strauss (2015) pain study involved five researchers and two 
years of systematic observations in wards, clinics, and hospitals in developing a pain 
management approach with opioids (Fagerhaugh & Strauss, 2015). Beta-Endorphin (BE), 
morphine, and analgesics topics included discussions on an experimental, theoretical, and 
observational research basis for pain management. For the pain management study, the 
hypothesis formulated was: The more frequently a hospice patient verbalizes perceptions 
of pain, the greater the administration of analgesics (opioids) should be (Grove, Burns, & 
Gray, 2013).  
Advancing Practice to Address Gaps 
For the project, the best available data from the specific literature returned 
integrative review findings that informed and supported the use of strong opioids for 
adults in hospice settings. The body of evidence highly approved AGREE II for an EBP 
appraisal of the CPG. The application of evidence-based care and AGREE II are the best 
tools to improve quality outcomes which target patients and communities. Many general 
studies indicated the same preference by giving superior approval to the AGREE II for 
the CPG assessment. A consensus of  the reviewed literature confirmed education on 
strong opioids, safety, and efficacy is needed to develop the CPC for patients in hospice 
care (AHRQ NGC, 2016) to address gaps. 
Local background and context: evidence to justify the problem. Hospice is an 
essential approach to addressing EOL needs (IOM, 2016). IASP (2015) research 
highlighted knowledge deficits, especially in the areas of pain assessment and dosage 
titrations as contributory to pain under-treatment. The IASP publication justified a need 
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to address problematic areas with opioid prescribing at the hospice site. The issues 
involved pain management dissatisfaction. Adverse ratings were expressed and 
documented in Deyta surveys. International studies selected from the literature review 
aligned with national guidelines for managing pain with opioids.  
Opioids were the choice drugs for pain, as the NGC 2015, cites this class offers 
expedient results. Analgesics, such as Morphine are the gold standard of strong opioids; 
they are a hospice cornerstone for managing pain, with the many benefits that various 
opioid formulations offered. Beneficial opioid combinations have come to be known as a 
therapeutic arsenal (Adversi et.al, 2014; ClinicalTrials.gov, 2015; Dekel, Tomasi, 
Vasarri, Gori, Kelly, 2014; NGC, 2016).  
Findings within the literature were practically relevant as severe pain often 
require rapid titration with hospice care (American Journal of Hospice and Palliative 
Medicine, 2015; Wells et. al, 2017). The evidence findings accommodated all the PICO 
elements and questions for an effort aimed at quality comfort measures. The DNP project 
offered up an opportunity to apply KSAs with CPG. When EBP was followed 
practitioners embraced care to the full extent and scope of their training as described in 
The Future of Nursing: Leading Change, Advancing Health (IOM, 2016). Years ago, on a 
national platform, the IOM demanded a safer health care system in the landmark reports 
Crossing the Quality Chasm and To Err Is Human.  
It is important to examine this topic in the first place to address widespread gaps 
with resources and what is actually done in practice. Equally important is the fact, it was 
in 2012 when there was a public awareness campaign from NHPCO’s Caring 
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Connections, dispelled myths about pain (NHPCO, 2015b) that disproportionally and 
disparagingly effect EOLC. Since that time, due to the prevailing thoughts as the basis for 
the campaign, it was then evident more advancement with pain and pain treatments are 
needed with hospice care.  
Some evidence sources utilized to drive the CPG production were the scholarly 
literature, EBP processes, frameworks, relevant models, and theories. Aside from 
theoretical approaches to developing the practice to solve pain control issues some of the 
articles aimed at political reactions on how society deals with pain. Moynihan (2015) 
propositioned a guideline designed to mimic existing pain management principles 
dependent upon etiology and severity.  
Unsurprisingly, colleagues largely support a CPG development for relevant 
knowledge and better pain relief that is readily available for practitioners (Callahan, 
Breakwell, & Suhayda, 2011). An EBP CPG was appropriate as opioids remain first-line 
therapy for moderate to severe pain. Evidence-based guiding practice always makes it 
possible no one dies in pain (Thomas, 2016) nationwide, regionally, or at the local 
community hospice site. 
The Robert Wood Johnson Foundation’s (RWJF), Community-State Partnerships 
in EOLC, received a grant to launch an initiative in California. The RWJF initiative 
worked with IDTs at 40 diverse hospitals from across the state in EOLC (NHPCO, 2017). 
EBP protocols developed from the initiative identified resources and tools most 
beneficial in producing a relevant pain control CPG. 
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Summary of local evidence relevant to the problem. At the project’s site, quality 
changes needed to occur to address pain issues. EBP sources of evidence contained 
quality supportive data compiled for comparison before commencing the project. 
Universal research on pain control was relevant to hospice and significant to clinical 
practice problems with pain management. Evidence on a global scale substantiated a 
compelling need to embrace strategies for EBP pain control methods on an urgent basis. 
The urgency of an EBP CPG had relevance to pain control problems regionally and 
statewide as quoted in research evidence done by the University of Tennessee (U.T.) 
cited, “… Little is known about hospice care…” (Lindley, Colman, & Meadows, 2017). 
Fellow associates at U.T. discussed relevant findings that will assist in culturally 
congruent EOLC for families (Mixer, Fornehed, Varney, & Lindley, 2014).   
The local evidence cited, EOLC is satisfying, meaningful, and fitting for patients 
facing death, and relevant to people’s daily lives (Mixer, Fornehed, Varney, & Lindley, 
2014). The U.T. data served as justified engaging local communities to foster benefits in 
EOLC. This study was relevant as it highlighted considerable knowledge gaps and 
guidance implementation due to unavailability of resources in the hospice community. 
Equally relevant were possible strategies discussed in the U.T. study which reiterated my 
need to undertake EBP actions strategically designed to apply the developed CPG locally. 
Implementing the guidance for prescribing safe, effective opioids was the 
responsibility of the local agency and providers. Local evidence from the U.T. research 
supported a basis to develop strategies that promote satisfying death experiences.  In the 
latter implementation and outcomes evaluative of the guidance, caregiver and behavioral 
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changes shall further contain prime measurements, which shall be compared knowledge 
level, as an outcome of interest. In a local context, guidance was relevant to practitioners 
who faced unmanaged pain problems in their practical duties. The developed CPG 
assumed guidance on opioids best-informed hospice prescribers decisions and justified 
clinical judgments. 
Summary of the local evidence on the problem justifying the PICO. The PICO 
justified the constant need for a CPG and EBP for hospice patients. The scoping literature 
review justified a remaining need for practice and educational endeavors for colleagues 
caring for those with incurable conditions.  Local hospice problems concerned an absence 
and lack of standardized methods to guide opioid prescribing. The PICO justified a CPG 
with safe, effective solutions for prescribing first-line drugs of choice, the opioids, was 
necessary for Hospice practitioners to manage patients pain issues properly.  
Locally, the staff’s KSA competencies were improved to enhance pain control, as 
two hospice metrics, (a) pain management principles and (b) education tenets were 
institutional priorities. The guidance developed for pain management considered AACN 
(2016) competencies, ANA (2016) professional standards of care, as well as reflected 
state, local, and federal contexts.  
White and Dudley-Brown (2012) stated metrics and nursing-sensitive indicators 
of a patient’s QOL. QOL is general perceptions of physical and mental well-being 
influenced by disease, injury, emotional stress, functional and pain status; as well as 
others. As inadequate pain relief affects QOL, practitioners are especially interested in 
correctly treating it (Terry, 2015); as to not, is a blatant failure of oath and obligations to 
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provide quality standard care. Competency is consistent with current professional care 
(IOM, 2016). KSA competencies addressed the gaps in federal, regulatory oversight, and 
accreditation standards with the CPG developed.  
Investigators studying hospice care and pain management problems presented 
evidence at a facility identified as the project’s site which concluded, “A number of 
clinical implications can be drawn from the study findings that hospice may use to 
improve clinical practice at the EOL” (Lindley, Colman, & Meadows, 2017). In the 
Scoping literature review, Targeted interventions were studies where participants in 
intervention groups received identical interventions; this is in contrasts to different 
treatments in tailored interventions (Melnyk & Fineout-Overholt, 2011).  
Another specific EBP guidance support came from systematic reviews, meta-
analysis, and several RCTs as some also were specific to targeted interventions. The 
highest levels of evidence found were in the Scoping literature review. Thus, based on a 
literature review, best education practices on KSAs in an educational offering are 
proposed herein, to inform learning on hospice issues and QOL measures. With EOLC, 
attaining desired health outcomes are consistent with current professional knowledge 
(IOM, 2017). Locally, practitioners are instrumental in overall improving the safety and 
quality benefits of EBP with opioid prescribing. At the Hospice site, competent EOLC is 
a huge, shared responsibility institutional-wise. 
Institutional context. Despite the unique delivery program with specialized 
hospice services, a review of the QI data indicated a problem whereas pain control was 
not well managed. The NWHC was an EOLC institution where most patients are at least 
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50 years of age. The daily census ranged from 100 to 300 patients, with 25,000 to 30,000 
Medicare home visits to over 1,000 patients conducted annually. Growth with hospice 
programs meant patients needed to be provided effective, consistent, safe, quality care, 
using EBP CPGs. 
It is known problems with opioid prescribing affects communities. Nationwide, 
this is a societal issue, which may be improved. QAPI (Appendix B) and Medicare’s 
Conditions of Participation [COPS] (Appendix B) were regulatory mandates, which 
allowed for measuring pain and comfort outcomes with for EOL services. Industry-
specific benchmarks and patients’ goals with QOL and symptom control (pain) were 
metrics used onsite as the QAPI program for outcomes management.  
In the shared governance institution, better management of pain was achieved by 
EBP and education that informed understanding of compliance to hospices regulations 
and standards of care. An implementation plan guided by the agency’s strategic vision 
and mission helped develop CPG. The use of EBP principles to develop the CPG 
permitted a QI initiative that also best aligned with the institutions’ goals and the hospice 
philosophy of care. The hospice philosophy and concept of care is a central model for 
EOL care (NHPCO, 2015a). 
Local Terms and Definitions: Terminology and Relevant Operational Processes 
 Deyta Patient Survey: A reliable survey tool at the site which displayed patient and 
family feedback on hospice services allowing stakeholders to see strengths and 
weaknesses in pain management processes clearly. 
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 Medicare’s Hospice Conditions of Participation (COPS; Appendix C): Allowed 
metrics and outcomes assessment to be measured through QAPI (Appendix C) for 
EOL hospice regulated by Centers for Medicare and Medicaid Services (CMS). 
 Outcome Concept Systems (OCS): A concept-driven manner to reach quality 
standards for EOLC, the conception was a valuable, reliable analytic solution to gain 
hospice insights, integrity, and clinical outcomes improvement (National Research 
Corporation, 2016). 
Operationally, OCS offered results-driven data intelligence, customer-centric 
healthcare across the continuum, and is recognized as an industry standard for QA 
benchmarking, QAPI compliance, and hospice quality reporting (National Research 
Corporation, 2016).  The CPG applied to caring processes promoted quality EOL 
outcomes for caregivers, patients, and organizational outcomes. Given this, the pain was 
expressly managed from the usage of expert guides developed for education practices. 
The CPG for opioid prescribing informed QAPI compliance to hospice regulatory 
standards. 
Regulatory awareness also had relevance extending beyond clinical circumstances 
to patient/family preferences; thus, guidance exceeded core measures once available and 
resourcefully coordinated amongst all stakeholders. Equally relevant to the CPG on 
prescribing strong opioids were contextual factors associated with core knowledge of 
state and federal regulations. The EBP CPG for safe, effective opioids drugs for hospice 
patients also covered cost acquisitions of prescribing opioids and prospective payments 
for services.  The CPG was quality pain control guidance in a federal and local context, 
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as COPS violations place the institution at financial, legal, and accreditation risks. EBP 
on KSA competencies were necessities, which improved pain outcomes onsite one 
patient at a time (individuals), in communities, and for society’s population, on a local 
(state), national, and federal level. 
State and Federal Contexts Applicable to the Capstone 
The agency that hosted the Capstone project was a Medicare-Certified facility. 
Public policy with Medicare Hospice COPS governs all Medicare-certified hospices. 
Health care policy is typically developed to deal with health care access, cost, quality, or 
a combination of the three. This agency’s problems with pain control outcomes were 
adverse quality services reported for pain control documented as high dissatisfaction 
rates. The patient’s dissatisfaction with pain control services exceeded ranges set by the 
CMS. The high patient’s dissatisfaction rates jeopardized facility reimbursements for the 
local home-based hospice, as federally, Medicare is the primary payer of services. 
Compliance to Hospice COPS was mandatory for the agency to receive Medicare 
reimbursements for hospice care services. 
Locally, mandates for the EBP CPG were developed with input from focus 
groups, consumers, experts in certain subject matters, healthcare clinical providers, and 
other professionals. The CPG developed provided a manner for the institution to follow 
best practices and meet hospice standards as there was regulatory oversight through 
frequent evaluations. According to ANA (2016), as a hospice standard of care, pain 
commands attention in that complaints of pain must be optimally managed and 
controlled. Optimal pain control was an integral metric and component of quality with 
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EOLC. Optimal pain control as a metric was a major part of the hospice practice and 
centered on therapeutic prescribing. The EBP CPG covered staff learning on correct 
opioid prescribing to control pain. The hospice agency reached and exceeded comfort 
benchmarks locally and nationally. 
A governmental agency, The Joint Commission (TJC) has pain management 
standards which are based currently on research findings. TJC is responsible the 
certification and accreditation of more than 20,000 health care institutions (TJC, 2017) as 
an independent, not-for-profit organization. TJC evaluates agencies to verify they 
consistently provide safe, effective, quality care. The CPG developed improved the safety 
of using opioid medications to address the federal contexts with TJC. Also, the hospice 
education occurred focusing on how to implement pain management guidance for the 
occurrence of satisfactory, therapeutic, comfort outcomes.  
The educational guidance incorporated EBP from the RJWF, which had a national 
program to promote high-quality pain management at the local hospice setting. The 
RJWF nationwide project on pain management applied to developing the EBP CPG 
locally and was relevant to inform public policy. Social justice implications of the CPG 
generated include the provision of safe and effective opioid prescribing to an underserved 
denigrated hospice population. Quality EOLC added to the momentum of the modern 
hospice movement. To affect social change, a standard EBP CPG was to provide 
consistent opioid prescribing for pain control that improved hospice care. 
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Hospice, Expertise, Insights Education Plan Process 
Hence, the EBP guidance developed considered TJC, WHO, AHRQ, and 
Medicare’s Hospice COPS (Appendix C) industry-specific policies, procedures, 
protocols, and regulations which were proposed herein as summarized in the following:  
1. Maintain a hospice setting where competence, control, and comfort are expected. 
2. Assess pain 100% of the time and administer analgesia with terminal illnesses. 
3. Staff must be knowledgeable of typical opioid prescriptions that are regularly 
scheduled and know how to use the WHO analgesic ladder to manage pain best. 
4. In addition to caregiver’s knowledge increase, there will be an increase in the 
percentage of practitioners correctly prescribing stronger opioids in six months. 
5. Should pain increase despite adequate treatment, go up on the WHO ladder. 
6. Strong opioids should be readily available to safely care for terminally ill adults in a 
hospice setting to decrease gaps in what is known and practiced.  
The RWJF foundations have a Promoting Excellence in EOL Care initiative, 
designed as a controlled trial testing the provision of comprehensive outpatient care and 
family caregiver support for seriously ill patients who have arrived at the intersection of 
curative and comfort care.  
To uphold a competency of AACN’s (2015) goals and objectives, the QI 
innovatively advanced interprofessional, team-based EOLC, in the form of practitioner 
lead EBP changes. The topic of educating caregivers and providers on KSAs with EOLC 
was a clinical interest. The issue at NWHC with pain control warranted a guideline 
development that was available and usable in various settings outside the hospice 
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specialty. To best affect organizational and a mission of positive social change, there was 
a concerted team effort amongst various disciplines using knowledge translation as a 
source of evidence through the application of the ACE star model. 
 Ace Star Model and Literature Supporting ACE 
The ACE star model was an inclusive framework to organize and present the EBP 
approach and processes, which vary point to point on the model (Melnyk &Fineout-
Overholt, 2011). The model depicted the Cycle of Knowledge Transformation (Melnyk 
&Fineout-Overholt, 2011). The theoretical basis for ACE was dependent upon the 
knowledge “form” in the five specific transformation stages (Melnyk &Fineout-Overholt, 
2011). According to Melnyk and Fineout-Overholt (2011), they are: 1.) Knowledge 
discovery, 2.) Evidence summary, 3.) Translation to practice recommendations, 4.) 
Implementation into practice, and 5.) Evaluation. The final step was evaluative and 
crucial to incorporate patients, providers, and systems outcomes to verify the EBP 
success.  
The ACE star model was effective with the educational component to help 
learners effectively capture the guidance developed on opioid prescribing. A meta-
analysis combined the Scoped literature review findings supported the QI project and was 
synthesized as evidence-based sources. A literature summary supported single statements 
to develop the guideline for adult hospice patients. The resultant CPG formed was 
translated into practice as a solution to specific opioid prescribing issues at the agency 
with adult hospice patients.  
50 
 
 
ACE served as theoretical support for developing and translating the guidance 
materials to practice. The ACE model was also a resource packaged for use with the 
clinical practice guidance and educational materials plan. The ACE conceptual 
framework was a vital evidence source and component for implementation planning. The 
CPG developed from combined sources of evidence was summarized and presented 
according to the corresponding point of the ACE model. The ACE star model of 
knowledge translation as illustrated in Melnyk and Fineout-Overholt (2011) as seen 
below is provided in Figure 1:  
 
Figure 1. The ACE star model. Copyrighted material (Melnyk & Fineout-Overholt 
(2011). Reproduced with expressed permission. 
Summary 
A meticulous, systematic literature review was performed. First, the Burns and 
Grove Problem Statement model with the PICO initiated the literature search. Next, the 
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John Hopkins evidence model was for a review of the abstracts. Once there was a review 
of abstracts, a comparison was for the strongest hierarchal evidence rankings relevant to 
agency’s prescribing issues.  
The narrower wording was, the more specific the computer retrieved and returned 
better qualities of evidence; the more words I added using Boolean terms like “or- 
allowing more than one term,” results broadened with lots of irrelevant data to sift 
through. Knowledge deficits with pain remained consistent, this issue along with correct 
opioid prescribing was uncovered in various specific and general articles. Eventually, 
vast pools of articles were further narrowed to extract applicable benefits, harms, and 
bias.  
Newton, Southall, Raphael, Ashford, and LeMarchand (2010) believed some 
narratives link pain control to stress as they highlighted strong evidence suggesting pain 
is stigmatizing. Shaw and Lee (as cited in Terry, 2015) found misconceptions about 
hospice pain control to a considerable degree, with specific knowledge deficits on 
malignant pain control. All articles cited were relevant to the EBP GPG developed as 
they provided data on variables affecting pain management, caregiver knowledge deficits, 
and opioid prescribing.  
The evidence body included sources from academic journals, books, magazines, 
and dissertations. Of note, studies directly focused on improving patient and family 
caregiver KSAs. Studies also tested targeted intervention effects to enhance patients and 
family KSAs (caregiver) behaviors regarding pain control. Most studies in pain 
management recommended intervening with clinician KSAs for best pain control, with a 
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number of studies that focused solely on changing clinician behaviors with opioid 
prescribing.  
Key findings strongly supported NP-lead education in a context of opioid 
prescribing guidance in hospice. Theoretically, other attributes reflected three 
classifications: NPs, the patient, and NP-patient education (Zaccagnini & White, 2011). 
After the Scoped literature review, it was concluded once guidance on education is 
developed; IDT members will be used as the audience base to concentrate the mass of 
knowledge from evidence sources towards QI efforts. Peers consistently advised using 
ACE as the theoretical model with the AGREE II tool for the QI initiative.  
In conclusion, the Scoped literature review consistently justified relevant evidence 
which supported a need to address problems with pain and opioid prescribing for hospice 
patients. A panel of experts was the selected population chosen to provide AGREE II 
feedback in a formal review of developed materials to create the pain management 
protocol through correctly prescribing opioids. To meet goals for the pain guidance CPG 
developed, the improvement, achievement, and monitoring of quality long-term pain 
outcomes was designed from planned procedural steps. 
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Section 3: Collection and Analysis of Evidence 
Methodology  
This scholarly project consisted of the development of a CPG along with an 
implementation plan, long-term evaluation process, and educational materials that were 
formatively evaluated by an expert panel (Stetler et al., 2017). The first step to fully 
implementing the CPG and educational offering materials developed for appropriate 
opioid prescribing for hospice patients included evaluation processes and an expert 
review. The formal panel assessed the guidance for applicability to practice, relevance, 
fulfillment of regulatory requirements of the safety, and quality standards of hospice care 
among other items. 
I developed the guideline, implementation plan, evaluation process, and 
educational materials with the support of evidence and theory from sources that I 
identified and synthesized during my review of the literature. To assess all the materials I 
developed, I convened a panel of experts and peers. The formative and summative 
evaluations consisted of anonymous surveys in a confidential process. The same panel 
participated in both formative and summative reviews. The developed materials 
promoted standardized practices for practitioners to prescribe strong opioids adequately. 
As a final output of the formative and summative evaluations, the site received the 
completed materials as developed QI resources to be implemented. 
Development of the Guideline and Educational Materials 
I presented material data to reviewers describing the gap in care at the 
organization. Hospice patients not obtaining optimal comfort was the problem. Thus, the 
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data presented supported the best pain management approaches. A CPG for the provision 
of pain control and competent care is vital in the hospice community. The expert panel 
was reminded how onsite gaps in resources hinder carer’s abilities to master the KSAs 
effectively. Bridging the gap in resources is significant in all settings as it is expected that 
disciplines maintain proficiencies relevant to a prospective field. Mastery of KSA 
competencies was an expected requirement for appropriate pain management using 
strong opioids. 
Researchers have described three classifications: hospice care providers, the 
patient, and practitioner-patient education (Melnyk & Fineout-Overholt, 2011). I 
presented a team of experts with a literature synthesis that supported the findings on the 
importance of an effective CPG for pain control. Synthesized literature that I gathered 
from meta-analyses and summative reviews served as evidence towards a solution. 
Resources developed comprised a package of guidance materials, with the CPG as a 
primary component. 
The guidelines were a summary of consensus statements that I developed from 
existing findings of reliable hospice and palliative care organizations. Level I literature 
findings helped establish the guidelines. The John Hopkins’ evidence hierarchy classified 
Level 1 as the strongest support in the literature. I presented the Level I meta-analysis of 
RCTs collected on safe prescribing for practitioners to the panel of guidance appraisers. 
To assess the guidelines, I developed a reliable evaluation tool from a pre-existing 
instrument, the AGREE II (Appendix D). 
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I developed and tailored the educational products towards the staff’s KSA 
deficiencies. The ACE star model of knowledge translation was an adjunct to meet 
learning goals. ACE is consistently mentioned and highly recommended in the literature 
for establishing educational guidance (Melnyk & Fineout-Overholt, 2011). All materials 
were literature-driven by sound evidence in the development and implementation phases. 
Because of the evaluation processes, there were also colleagues in place to introduce and 
help sustain changes when the project got implemented later.  
Population Planned for the Formative and Summative Evaluations 
For the review of the materials I developed for this project, I purposefully selected 
an expert panel of team members as the population. The purposeful sample of 
participants to compose the formative group was an expert panel who possess the 
requisite knowledge and skill level to appraise the resource developments. Initially, 10 
stakeholders for the formative evaluation team of committee members consisted of: The 
chief operations officer ([COO]-administrator), two physicians (the medical director 
[MD] and assistant medical director [AMD]), one pharmacist, one nurse researcher with a 
PhD, a doctor of nursing practice student, one nurse practitioner (NP), the staff nurse 
educator (SNE), the patient care manager (PCM) with a master of science nursing (MSN) 
degree, and one registered nurse case manager (RN-CM).  
In Phase I, panel members utilized the AGREE II instrumentation (Appendix D). 
While seeking definitive feedback on materials for prescribing strong opioids, I explicitly 
needed experts with relevant credentials and an extensive background. I selected this 
expert panel as reviewers to obtain the most valuable feedback and appraisal possible for 
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immediate and long-term outcomes. The population that provided the summative 
evaluation of the developed materials was the same group of reviewers. Therefore, based 
on the results of this expert review, end users of the CPG had an exceeding level of 
confidence in the developed guidance as assessed by AGREE II users.  
Data Collection: Instrument- AGREE II 
I used the AGREE II tool to execute plans for the collection and analysis of 
formative feedback given by the experts on developed resources (Appendix D). After a 
routine IDT meeting, the consenting participants reassembled and used AGREE II. 
Developed resources were physically distributed in person as a package containing hard 
copies of all materials. The packet contained a draft of the guideline. Within the 
conference room, there were also models of developed materials on display as well. 
During the formative briefing, the panel received the summarization of the 
evidence in a presentation. The evidence summary for the project supported the use of the 
AGREE II tool for the formal appraisal. One criterion for panel selection was that 
members needed to be equipped to use the AGREE II. Given the panel’s expertise, the 
AGREE II users had the abilities, familiarity, and training required for the assessment. 
Nevertheless, I presented the panel members with written and verbal instructions to 
remind them how to maximize use of the AGREE II tool. These explanations reinforced 
the differentiation between positive versus negative ratings on the AGREE II seven-point 
linear scale and areas where feedback was designated (Appendix D). 
After the briefing in the conference room, the panel dismissed to the facility’s 
onsite library, located elsewhere on the premises. The expert appraisers had sole use of 
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the library during a specified period to appraise developed materials. The reserved time 
was for the provision of anonymity and confidentiality of the AGREE II users. They were 
allowed to select any computer with a pre-downloaded intranet version of the AGREE II 
tool. There were also paper and pencil versions of the AGREE II available for panel 
members who opted out of the electronic format. 
Once individuals completed the formal appraisal, an electronic submission prompt 
allowed for a secure upload of the user’s feedback. Otherwise, a secured lock box was 
designated for manually completed AGREE II appraisals. After the panel of experts 
received, completed, and returned the AGREE II validation tool survey, I retrieved the 
feedback electronically or manually (Appendix D). After retrieval, I synthesized and 
analyzed the data.  
If the panel recommended any changes, I made the modifications based on the 
formative evaluation. The same panel of experts reconvened for a review of the revised 
materials to complete a summative evaluation. In the summative review process, I 
represented and redistributed materials to the panel. There was a recollection of the 
AGREE II instrument. The data retrieval in the summative review was in the same 
confidential manner as with the formative review. Instructions and the AGREE II 
Instrument participants were utilized for both reviews are in Appendix D and E. The 
anonymously collected feedback on the AGREE II forms were reviewed for analyses.  
Protection of human subjects. Fulfilling criteria within this project posed no 
identifiable risks to those select participants deemed suitable for and who consented to 
participate in this evaluation of the project. The purposeful sample composing the expert 
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panel consisted of consented stakeholders who volunteered to review the developed 
materials. 
The panel of experts chosen provided confidential, anonymous feedback using the 
AGREE II instrument (Appendix D). I did not have any control over the expert panel. 
The project did not contain any endorsements with implementation or evaluation and was 
void of any special entitlements or exchanges. There were not any obvious ethical 
indications to barriers which may have prohibited completion of the project.  All 
feedback responses were confidential and anonymous, and participation was voluntary. 
There were provisions for proper monitoring and protection of data. There was ethical 
discernment of the data analysis, results, interpretation, and dissemination processes. An 
application was submitted to the Walden Institutional Review Board for support of the 
project, prior to commencing it. 
Data analysis. The data analysis of a guideline developed as guidance on 
effective prescribing opioids entailed using the AGREE II instrumentation domains with 
both reviews (Appendix D). The Statistical Package for the Social Sciences (SPSS) was 
the process selected the analyses. For the expert panel using the tool, written and verbal 
explanations explicitly described the instrument (Appendix D). The instructions were 
verbalized verbatim to AGREE Trust (2009) as 
The AGREE II consists of 23 key items organized within six domains followed 
by two global rating items (“Overall Assessment”). Each domain captures a 
unique dimension of the guideline quality. Domain 1. Scope and purpose are 
concerned with the overall aim of the guideline, the specific health questions, and 
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the target population (items 1-3). Domain 2. Stakeholder Involvement focuses on 
the extent to which the guideline was developed by the appropriate stakeholders 
and represents the views of its intended users (items 4-6). Domain 3. The rigour 
of development relates to the process used to gather and synthesize the evidence, 
the methods to formulate the recommendations and to update them (items 7-14). 
Domain 4. Clarity of presentation deals with the language, structure, and format 
of the guideline (items 15-17). Domain 5. Applicability pertains to the likely 
barriers and facilitators to implementation, strategies to improve uptake, and 
resource implications of applying the guideline (items 18-21). Domain 6. Editorial 
independence is concerned with the formulation of recommendations not being 
unduly biased with competing interests (items 22-23). 
The emphasis was on areas within the AGREE II form designated for comments, 
concerns, advice, and recommended changes (Appendix C). Guidance developers can use 
the tool to ensure their processes are robust (AGREE, 2009). An expert panel of assessors 
can be used to conduct a formal review (AGREE, 2009). In a formal review, there is a 
judgment to the quality of processes in developing guidance before practice (AGREE, 
2009). The panelists were highly trained for this task, their estimated assessment of 
guidance using AGREE II took about 1.5 hours. The experts were alone for the specified 
1.5-hour time frame anticipated as the completion time. 
The panel was also instructed to place the completed forms in a secure feedback 
box at a designated location (Appendix D). Feedback from the AGREE II forms was 
retrieved (Appendix D). There was an application of Microsoft Excel, and SPSS applied 
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to the analysis process. Any quantifiable data from the boxes were categorically 
organized. There was a meticulous check that all the data was gathered and synthesized. 
The focus was turned to the comment boxes; which contained the panel’s feedback 
(Appendix D). I entered the data into SPSS software for analysis. The feedback was then 
analyzed for the relevant subject matter. In addition to a superior rating with internal 
consistency, the relevancy of AGREE II was amplified by reviewed Cronbach’s alpha 
reliabilities in previous studies and bolstered for the Likert scale aspect of it (Terry, 
2015). The tables generated were displayed as Descriptive statistics in the SPSS process. 
Implementation plan. The colleagues who participated in the review were 
empowered to implement and sustain changes. The site had access to the availability of 
the guidance developed and proposed herein to help substantiate new approaches with the 
CPG. This guidance served a purpose to meet quality standards, metrics, regulations, and 
direct decisions. The EBP CPG ultimately translated into clinical practice as a theory-
based guideline using the ACE star model of knowledge translation. As a part of the 
educational undertaking, a highly preferred applicable theory was the Theory of 
Unpleasant Symptoms (TOUS). TOUS was relevant and was also well-suited for the EBP 
journey (Grove, Burns, & Gray, 2013) when educating staff, patients, and families about 
quality care. I strongly advised the NWHC site to use this method as theories underpin 
the nursing practice discipline.   
Strategies such as Aim Statements were used with a QI focus to evaluate 
individual dimensions of the guideline. A framework helps incorporate presenting the 
EBP and potentially assisted in transforming innovative changes at the site. Thus, overall, 
61 
 
 
AGREE II was proposed framework as a premise for the site to address educating the 
staff on their gaps in practice. The ACE model was also used to help the site integrate 
assessment, performance improvement, and evaluation. 
Long-term evaluation plan. As initiatives promoted awareness in pursuing an 
ongoing drive for excellence extended beyond this Capstone, I offered the site a plan for 
long-term evaluation. The clinical algorithm planned suggested that every six months; the 
agency looked at satisfaction scores and compared pre-implementation to post-
implementation results to determine if they were meeting their outcomes marks. I 
suggested they use the unfavorable Deyta survey results as a comparison to assure they 
are progressing forward toward the intended goals. Deyta survey questions are in 
Appendix B. The site received all the materials developed for this project to help in their 
future outcomes evaluation. 
Evaluation Plan 
 I consulted the expert panel to provide me with formative and summative data. 
After completing any modifications, there was an acceptance evaluation of the final 
product. The Expert panel’s feedback assisted in determining the feasibility and 
validation of the proposed solutions towards practical improvements. By the strong 
consideration given to credentialing, backgrounds, and experience of the AGREE II 
users, they were highly capable of providing credible feedback. There was a synthesis of 
the Expert panel’s appraisal of assessed materials. Their feedback underwent a detailed 
analysis.  
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The analysis covered several AGREE II domains (Appendix D). Domains within 
the AGREE II assessment included the overall rating of the guideline (Appendix D). 
Thus, the Expert panel’s appraisal helped determine whether the content of the materials 
was sound, valid, and applicable to the hospice site. Intense vetting was relayed in the 
scoring as stakeholder’s rated the materials during the assessment and appraisal process. 
High scoring assured the materials were properly developed and underwent intense 
vetting. Therefore, a 100% approval of the draft guideline from all 10 Expert reviewers 
was the goal sought.  
Summary 
A full review of the guidelines, materials, implementation, and long-term 
evaluation plan using reliable processes was essential. Thus, in this project methods 
included sampling, in-house test piloting prior to roll out, in addition to the summative 
and formative evaluation processes. Within the methods, the expert panel of stakeholders 
used the AGREE II to summatively and formatively evaluate materials. Therefore, the 
developed resources were backed by a high level of confidence and certainty when 
correctly implemented. After the AGREE II comprehensive appraisal and thorough 
vetting, there was a subsequent offering of the materials to NWHC’s administrative 
authority, the Director of Operations (DOO). In turn, the gaps addressed were between 
what is known about good EOLC and what was practiced at Hospice site. A developed 
CPG assured that gaps in pain control were considerably narrowed or closed and those 
measurable positive outcomes with patient care and satisfaction occurred. 
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Section 4: Findings and Recommendations 
Practitioners are to fulfill solemn and dutiful obligations to contribute to 
appropriate prescribing options for hospice patients that benefit other disciplines. Yet, 
pain control problems exist. Successful implementation of the CPG demonstrates that 
applicable, innovative, available guidance averts adverse outcomes with pain.  
Summary and Evaluation of Findings 
In this section, I will present the overall findings of the project. The project was 
the development of a CPG for hospice staff, patients, and families on appropriate opioid 
use. A two-step process was used to evaluate the CPG before finalizing the guidance. 
This process included a summative and formative evaluation.  
Formative evaluation. Ten individuals performed the formative evaluation. The 
formative group consisted of the COO, two physicians, a pharmacist, a nurse researcher, 
a DNP student, an NP, an SNE, a PCM, and an RN-CM. The formative evaluation 
included ten questions. Each participant returned evaluations within the time allotted. The 
final review included all ten responses. For further explanation, please refer to the 
following table: 
Table 1  
Formative Group CPG Questionnaire and Responses 
Developer questions Participants’ responses 
 Yes No Comment(s) 
1. Is there a clear understanding of all 
statements contained within the CPG?  
If not, please provide necessary 
feedback on any unclear statements or 
terminology requiring clarification. 
1 9 Participants suggested a consensus 
statement be separated into two 
independent statements. 
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2. Are the CPG overall goal(s), 
objective(s), and sources of evidence 
described in detail with expected 
benefits of the guideline specific to the 
hospice problem and topic?  
10   
3. Was there a description of the target 
audience of the resource development 
(e.g., hospice metrics, standards of 
care, to inform practice)? 
10   
4. Please provide feedback on the CPG; 
i.e. is it appropriate to the targeted 
audience (hospice patients)?  
10   
5. Is the CPG appropriate to the targeted 
setting?  
Does it appear to capture the current 
state of clinical circumstances?  
10 
10 
 
  
6. Is there a description of the intended 
CPG audience (e.g. hospice specialists, 
medical directors, physicians, 
institutional or clinical leaders, senior 
administrators, families, patients?) 
10   
7. Do resources appear to consider and 
capture patients’, families’, 
community’s organizational and 
societal preferences and views?  
Why or why not?   
Please provide comments on possible 
barriers to implementing this CPG and 
immediate concerns foreseen with the 
CPG implementation.   
8 2  Comprehensive, Thoughtful, 
Simplicity of use; 
Serves as a reference, 
Teach-back method; 
Offer a question and answer session 
for the CPG; 
Clarify staff concerns of perceived 
ambiguity with resources; 
Address fears of pain with the 
reassurance that appropriate 
protocols have been established; 
Provide training and professional 
development for all new and current 
employees; 
Encourage staff adoption of the 
CPG to address appropriate 
prescribing of safe, effective opioids 
for adult hospice patients; 
Barriers: cost, demandsa 
8. Do you think that use of the guideline 
will achieve the following stated goal 
and objectives?  
The CPG will promote satisfactory 
feedback survey data and avert adverse 
pain control outcomes in future 
quarters.  
If not, please provide necessary 
comments as to how goals and 
objectives may be modified and 
achievable. 
10  Alternatives offer flexibility with 
prescribing safe, effective opioids 
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9. Is sufficient information included from 
each appraisal domain to sustain the 
CPG and protocols developed?  
If you answered no, please comment 
with information on potentially omitted 
areas you feel should be addressed and 
included.  
9 1 One participant suggested a fact 
sheet that deals with the nationwide 
growing opioid epidemic to help 
influence providers on the 
significance of proper opioid 
prescribing. 
10. Are there any areas you would like to 
modify or change or added to this 
guideline? If yes, please state area and 
provide suggestions. 
9  Present to the organization 
Disseminate to the healthcare staff 
Obtain data over a six months’ 
period beyond initial 
implementation for a summative 
evaluation of patient satisfaction 
from statistical data. 
Facilitate translation of evidence as 
needed 
a Participants PCM & RN-CM offered no feedback for Question 7. 
 
There was overwhelming cooperation with valuable responses for the questions. 
However, on one question, two individuals did not offer the requested comments for 
open-ended questions relevant to the actual CPG. The formative evaluators offered a high 
degree of superior quality feedback on the format and structure of the CPG. Overall, their 
recommendations were in regards to the end-users and targeted audience population for 
the CPG.  
After the formative evaluation, I revised the CPG according to the feedback 
offered. Overall, the formative group agreed that the CPG provided clear and concise 
EBP for healthcare practitioners to manage pain with appropriate opioid prescribing 
adequately. Once I finished revising the guideline, I redistributed it to the group for the 
summative evaluation. 
Summative evaluation. The summative evaluation included the same ten 
individuals. The group returned the completed AGREE II Tool within the designated 
period. Criteria for inclusion in the summative group included credentialing, expertise, 
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professional experience, and status as a current full-time practitioner in the hospice 
setting. The 10 participants were all employed at the same hospice organization in an 
urban area in the NW United States. 
In Domain 1, participants addressed the purpose and scope of the CPG (Please 
refer to Appendix D.) All participants scored statements applicable to the project in this 
section. A 100% domain score was obtained. Stakeholder involvement was addressed in 
Domain 2 with statements applicable to the project. The domain score was 97.5%. 
Domain 3 addressed statements regarding rigor of development with the domain score as 
99.7%. Domain 4 addressed statements about the clarity of presentation. Each participant 
responded to every statement within this domain. The domain score was 100%. 
Items about applicability were addressed in Domain 5. A 97.5% domain score 
was obtained.  Domain 6, containing statements regarding editorial independence, had a 
domain score of 100%. The overall CPG appraisal contained the subsequent statements: 
(1) Rate the overall quality of the CPG. (2) This CPG is recommended for use. The 
overall rating of the guideline was 98.1%, and 100% of the participants accepted it 
without modifications. 
Table 2  
AGREE II Summarized Data 
AGREE II DOMAIN Percentage (%) Score 
Domain 1: Scope and Purpose 100% 
Domain 2: Stakeholder Involvement 97.5% 
Domain 3: Rigor of Development 99.7% 
Domain 4: Clarity and Presentation 100% 
67 
 
 
Domain 5: Application 97.5% 
Domain 6: Editorial Independence 100% 
Overall Guideline Assessment 98.1% 
Recommend This Guideline for Use 100% Yes without modification 
 
Discussion of Findings. The developed CPG offered practitioners 
recommendations on appropriate opioid prescribing. EBP guidance was necessary for 
patients receiving EOLC and experiencing unmanaged pain. CMS expects practitioners 
to provide comfort to all hospice patients receiving EOLC. An established CPG advised 
how to safely and effectively prescribe strong opioids. The standardized CPG ultimately 
resulted in increased patient satisfaction, decreased pain, and unnecessary discomfort, 
which improved QOL for hospice patients. It is anticipated the recommended practices 
may further lead to a standardization of quality care in other hospice and healthcare 
programs. The formative group responses reinforced a need for the CPG, while the 
summative group’s 100% approval validated the EBP CPG. 
Implications for practice/social change. Intellectual appraisal processes for a 
CPG on opioids included retrieving innovative evidence, adopting newer versus 
conventional practices, and theorizing outcomes. Societal exceptions, patterns, values, 
and preferences were considered in developing guidance. The social intent of the CPG 
centered on improvement of pain management practices through reflective thinking by 
empowering practitioners’ clinical decision making with opioid prescribing. The 
guidance embracing health care policy and social policy that positively influenced patient 
outcomes is important and relevant to practitioners. As pain crosses social lines, 
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overcoming EOLC barriers by developing practice resources not only resulted in better 
QOL, but it positively impacts care costs and efficiency. Guidance on appropriate opioid 
prescribing was socially acceptable for producing a practical solution for EOLC was 
made readily available to address clinical and social issues. The newly developed CPG 
profoundly affects how society treats EOLC patients. 
Project Strengths and Limitations 
 All the individuals in the formative and summative groups had lengthy 
employment in hospice settings. The group’s extensive hospice background strengthened 
the evaluations of the CPG. With the group’s varying levels of credentials and insight, 
they professionally collaborated to assist with the correct terminology and formatting for 
the CPG. Moreover, all participants in the formative and summative groups were end 
users. A limitation of the project is that two of the 10 participants in the formative group 
withheld feedback for particular questions in evaluating the project. Due to the relatively 
small number of participants, such omissions limited the data more than they would have 
with a larger group of respondents. 
Summary 
I developed the EBP CPG to promote safe, effective prescribing of opioids for 
adult patients to fulfill gaps between theory and practice. The CPG, designed for hospice 
settings, has the potential to gain nationwide and perhaps global success. The CPG is 
comprehensive, meaning that it includes all areas of key content by capturing the clinical 
state of hospice. The CPG achieves stated objectives and meets the needs of the targeted 
audiences. The CPG aids practitioners in appropriately prescribing strong opioids to meet 
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and exceed hospice standards and metrics in regards to patient care. 
70 
 
 
Section 5: Dissemination Plan 
Development of a Guideline for Hospice Staff, Patients, and Families on Appropriate Opioid Use 
by 
Trenika Alexander-Goreá, DNP Studies, FNP-BC 
Walden University 
Introduction 
Dissemination is an essential component of scholarship. After the CPG develops, the guidance 
needs disseminating. The IOM calls for the development of an effective infrastructure to support the more 
rapid evidence-based prescribing of opioids application with EOLC. Dissemination is an avenue to bridge 
theory and EBP to quality patient care. Dissemination of the Capstone scholarship and theoretical practice 
reflects a reality whereas hospice providers may maximize patient comfort by properly prescribing strong 
opioids. Solid scientific theoretical evidence reflecting QI domains will be disseminated, so practitioners 
prescribe opioids safely and effectively. I plan to submit the manuscript to the Hospice & Palliative 
Medicine International Journal. 
 
Objective:  To develop an EBP CPG for practitioners with guidance on prescribing strong, effective, and 
safe opioids to hospice patients.  
 
Background:  The aim of the project was to develop an EBP CPG for HCPs practicing in EOLC.  The 
focus of the project was on an urban hospice located in the NW region of the U.S.   
 
Method: A formative group appraised the CPG and offered feedback on the guidance before distribution of 
the CPG to a summative group of expert panelists.  The summative group re-assessed the CPG for the 
applicability, validity, and quality of the CPG by using the Agree II Tool.  
 
Participants: The formative group contained 10 participants.  The formative group included the COO, two 
physicians, a Pharmacist, a Nurse Researcher, a DNP student, an NP, an SNE, a PCM, and an RN-CM. The 
summative group included the same 10 participants from the formative group. 
 
Results: Feedback from the formative group resulted in a revised CPG preceding the distribution of the 
CPG guideline to the summative group.  The summative group recommended and accepted the CPG with a 
100% approval without any modifications. The quality of the CPG was scored at 98%. 
 
Conclusions: The CPG for safe, effective opioid prescribing to adult hospice patients guides hospice 
practitioners who provide EOLC to patients receiving strong opioids for appropriate pain control.  
 
Keywords: “Hospice”, “terminal illness”, “comfort care”, “ethical end-of-life care”, “hospice care”, 
“palliative care”, “definitions of pain”, “theory”, “pain and guidelines”, “actively dying and narcotics”, 
“practitioners and opioids”. 
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INTRODUCTION 
Providing effective, safe prescribing from practitioner to patients in regards to strong opioids is a 
significant problem in hospices nationwide.  Prescribing safe, effective opioids by hospice practitioners is 
imperative for several reasons.  Providing effective opioids in hospice should consist of more than just 
prescribing, but should also allow for strong and safe opioids from hospice providers to patients.  Family 
members are the center of hospice services and can serve as a reliable caregiver in assisting the patient with 
safe and effective use of prescribed opioids. Providing safe and effective opioids to hospice patients not 
only benefit the family and patients, but it also permits hospice professionals, local, and federal regulators 
to evaluate the quality of services provided with hospice care.  
BACKGROUND AND OBJECTIVES 
Practitioner’s prescribing of opioids can be challenging for many hospice providers nationwide. Strong 
opioids offer needed comfort to patients and family members once prescribed safely and effectively. 
Hospice practitioners have a specific responsibility in prescribing opioids in EOLC.  The hospice 
practitioner role in prescribing strong opioids is unique. In the unique role, the provider’s EOLC should 
coincide with patient expectations and national standards.  Guidance for safe and effective prescribing of 
strong opioids for hospice patients should become the standard for all hospice programs.  This CPG is a 
recommendation for consistent guidance when practitioners prescribe strong opioids to hospice patients. 
Objectives of this manuscript are to examine and review the developed CPG, which consists of prescribing 
safe and effective strong opioids for hospice patients.  It is imperative patients receive strong, safe, and 
effective opioids in hospice with EOLC. 
Practitioners are expected to know appropriate protocols when prescribing opioids in EOLC.  Professional 
competency is an ANA standard of care. Practitioners have a role in providing the highest quality of 
remaining life and support at the EOL for both patients and their loved ones; this is traditional, accepted, 
and expected (ANA, 2016). Fidelity to patients requires expertise in relieving suffering including a 
provision of comfort (ANA, 2016).  Various methods of unsafe, ineffective opioid prescribing in hospice 
ultimately affect the level of comfort and satisfactory outcomes for patients and facilities.   
An effective, standardized CPG on providing safe, effective prescribing of strong opioids is imperative for 
the patient’s QOL. The standardization of an adequate CPG is necessary for staff obligations and to achieve 
successful patient outcomes.  Standardizing a CPG is warranted for organizational benchmarks leading to 
an improved quality of care. TJC (2017) has issued standards for pain-management, to survey for 
compliance by adding patient-safety goals. Facilities are to have devised policies and procedures requiring 
pain intervention for reports of pain experienced with a terminal illness (TJC, 2012). One solution proposed 
for a hospice shortcoming with pain in EOLC is to relieve suffering and QI for the dead and living. Pain 
control is attainable through comprehensive pain management, particularly for patients with life-
threatening and terminal illnesses. Thus, a standardized CPG for providing safe and effective strong opioids 
is usable in hospice and other practices.  
GUIDELINE EVALUATION 
PROJECT METHOD 
A Literature scope revealed just enough proof for EBP approaches to pain management in hospice settings, 
where standardization of a CPG for prescribing strong opioids is nonexistent in many hospices. 
Accordingly, none of the literature reviewed stated, ‘allow terminally ill patients to suffer unmitigated.’  
The literature review and data analyzed from the formative feedback and summative group strengthened 
the validity of the CPG developed. Primary end-users reviewed the CPG before finalizing the EBP 
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guidance. The CPG acceptance by Reviewers with an Expert consensus was the goal. These ensured the 
completion of necessary changes for a 100% accuracy, approval, and acceptance of the CPG.  
METHOD: FORMATIVE GROUP 
An Expert consensus was used to formulate the CPG. There was the distribution of a questionnaire with ten 
items to the formative group.  The formative group had a COO, two physicians, a Pharmacist, a Nurse 
Researcher, a DNP student, an NP, an SNE, a PCM, and an RN-CM as participants.  Two participants left 
blank responses on one item.  Participants were presented the AGREE II tool and advised to complete the 
forms at a designated location. The group had direct access to the tool containing many opportunities to 
provide feedback.  Many methods were made available for contacting the project developer for concerns or 
questions.  Table 1 is an itemized list of the questions with participant feedback. 
METHOD: SUMMATIVE GROUP 
There was a redistribution of the AGREE II Tool to the same 10 participants from the formative group. The 
AGREE II users of the Summative group have an extensive practice career at the urban hospice located in 
the NW region of the U.S. Each participant returned the completed feedback over the designated period. 
Therefore, expert input for the evaluation, recommendations, and overall scoring for the quality of the CPG 
developed came from all 10 AGREE II appraisals. 
 
Table 3.  
Formative Group Questionnaire CPG 
Developer Questions Participant’s Response 
1. Is there a clear understanding of all statements 
contained within the CPG?  
If not, please provide necessary feedback on 
any unclear statements or terminology 
requiring clarification. Please suggest 
modifications and adjustments needed. 
Yes:  
No: 10 
Comment (s):  
  
2. Is sufficient information included from each 
appraisal domain to initiate the CPG the 
developed with recommended statements (1-
12)? Should optional comments (13-23) be 
included in the CPG?  
Yes: 10 
No: 
Yes: 10 
No:  
Comment (s): 
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If you answered no, please comment with 
information on potentially omitted areas you 
feel should be addressed and included.  
3. Was there a description of the target audience 
of the resource development (e.g., hospice 
metrics, standards of care, to inform practice)? 
Yes: 10 
No: 
Comment (s): 
4. Please provide feedback on the CPG; i.e. is it 
appropriate to the targeted audience (hospice 
patients)?  
Yes: 10 
No: 
Comment (s): 
5. Is the CPG appropriate to the targeted setting? 
Does it appear to capture the current state of 
clinical circumstances?  
Yes: 10 
Yes: 10  
No: 
No: 
Comment (s): 
6. Is there a description of the intended CPG 
audience (e.g. hospice specialists, medical 
directors, physicians, institutional or clinical 
leaders, senior administrators, families, 
patients?) 
Yes: 10 
No: 
Comment (s): 
7. Do resources appear to consider and capture 
patients’, families’, community’s 
organizational and societal preferences and 
views?  
Why or why not?   
Please provide comments on possible barriers 
to implementing this CPG and immediate 
Yes: 10 
No: 
Comment (s):  
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concerns foreseen with the CPG 
implementation.   
8. Are the CPG overall goals and objective(s) 
described in detail with expected benefits of 
the guideline specific to the hospice problem 
and topic?  
Yes:10 
No: 
Comment (s): 
9. If you were employed at a different hospice 
facility experiencing challenges meeting 
benchmarks and metrics in a pain setting, 
would you feel comfortable implementing and 
adhering to the prescribed protocol? 
Yes:10 
No: 
Comment (s): 
10. How may this CPG be implemented 
organizationally and in various pain settings, 
or how might the CPG have added value if 
you or your family utilized hospice services 
and had to be prescribed opioids? 
10 Participants responded:  
Comment (s):  
Present to the administration. 
Present to hospice staff.  
Obtain outcomes data over a six-
month period post implementation for 
statistical data to re-evaluate patient care 
satisfaction. 
Patient returns and follow-ups, phone 
calls, use of electronic and digital media. 
Address fears of unmanaged pain and 
give reassurance as to how safe and effective 
opioids will be prescribed. 
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Adequate training for all new 
employees with professional development and 
training for current staff at the hospice site.  
Encourage staff implementation of 
the CPG and address time allotted to perform 
associated tasks properly. 
The optional CPG will facilitate 
patient satisfaction with pain management 
with enhanced opportunities for new patient 
referrals to the hospice facility in the future for 
delivering EOLC.  
Use reminders around the site for 
staff to adopt the newly developed CPG.  
 
DATA ANALYSIS 
 
The AGREE II consists of 23 key items organized within six domains followed by two global rating items 
(“Overall Assessment”). Each domain captures a unique dimension of guideline quality. Domain 1. Scope 
and purpose are concerned with the overall aim of the guideline, the specific health questions, and the 
target population (items 1-3). Domain 2. Stakeholder Involvement focuses on the extent to which the 
guideline was developed by the appropriate stakeholders and represents the views of its intended users 
(items 4-6). Domain 3. Rigour of development relates to the process used to gather and synthesize the 
evidence, the methods to formulate the recommendations and to update them (items 7-14). Domain 4. 
Clarity of presentation deals with the language, structure, and format of the guideline (items 15-17). 
Domain 5. Applicability pertains to the likely barriers and facilitators to implementation, strategies to 
improve uptake, and resource implications of applying the guideline (items 18-21). Domain 6. Editorial 
independence is concerned with the formulation of recommendations not being unduly biased with 
competing interests (items 22-23). 
 
Table 4. 
AGREE II SUMMARIZED DATA 
 
AGREE II DOMAIN Percentage (%) Score 
Domain 1: Scope and Purpose 100% 
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Domain 2: Stakeholder Involvement 97.5% 
Domain 3: Rigor of Development 99.7% 
Domain 4: Clarity and Presentation 100% 
Domain 5: Application 97.5% 
Domain 6: Editorial Independence 100% 
Overall Guideline Assessment 98.1% 
Recommend This Guideline for Use 100% Yes without modification 
 
RESULTS 
 
The first domain addressed the CPG’s scope and purpose in three statements.  Each of three statements 
applied to the CPG, and all 10 participants responded.  There was a 100% achievement with the first 
domain. The second domain had four statements addressing stakeholder involvement. Four appraisers 
recorded a 6/7 score in this area.  The domain score was analyzed to reflect the input.  A domain score of 
97.5% was obtained.  The third domain had seven statements to appraise rigor of development of the CPG.  
Item 14, which was ‘A procedure for updating the guideline is provided’ did not apply; therefore, scoring 
with the third domain was adjusted accordingly to 99.7%. Clarity of presentation was addressed in the 
fourth domain by four statements. The participants responded to all statements in this domain.  A 100% 
rating was obtained in this domain based on input from the 10 participants.  The fifth domain addressed the 
applicability of the CPG through three items.  97.5% was accumulated for this domain. Editorial 
independence was addressed in the sixth domain as statements 22 and 23. 100% approval was obtained for 
the last domain.  The overall CPG appraisal had two statements, which were: “I would recommend this 
guideline for use” and “Rate the overall quality of the guideline.” Overall, the CPG was appraised at 
98.1%, recommended, and accepted with an expert consensus for frontline practitioner usage at 100% 
without modification from all 10 participants. Scoring results by appraisal domain are referenced in Table 
2:  
Domain 1: Scope and Purpose 
Domain 1  Item1 Item2 Item3 Total  
% 
Score           
Appraiser1 7 7 7 21 100%      
Appraiser2 7 7 7 21 100%      
Appraiser3 7 7 7 21 100%      
Appraiser4 7 7 7 21 100%      
Appraiser5 7 7 7 21 100%      
Appraiser6 7 7 7 21 100%      
Appraiser7 7 7 7 21 100%      
Appraiser8 7 7 7 21 100%      
Appraiser10 7 7 7 21 100%      
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Total Domain 1 63 63 63 63 100%           
 
Domain 2: Stakeholder Involvement 
Domain 2  Item4 Item5 Item6 Total 
% 
Score           
Appraiser1 6 7 7 20 95.2%      
Appraiser2 7 7 7 21 100%      
Appraiser3 6 7 7 20 95.2%      
Appraiser4 7 7 7 21 100%      
Appraiser5 6 7 7 20 95.2%      
Appraiser6 7 7 7 21 100%      
Appraiser7 6 7 7 20 95.2%      
Appraiser8 7 7 7 21 100%      
Appraiser10 7 7 7 21 100%      
Total Domain 2 59 63 63 185 97.5%          
 
Domain 3: Rigor of Development 
Domain 3  Item7 Item8 Item9 Item10 Item11 Item12 Item13  Item14 Total  
% 
Score 
Appraiser1 7 7 7 7 7 6 7 *N/A 41 97.6% 
Appraiser2 7 7 7 7 7 7 7 *N/A 42 100% 
Appraiser3 7 7 7 7 7 7 7 *N/A 42 100% 
Appraiser4 7 7 7 7 7 7 7 *N/A 42 100% 
Appraiser5 7 7 7 7 7 7 7 *N/A 42 100% 
Appraiser6 7 7 7 7 7 7 7 *N/A 42 100% 
Appraiser7 7 7 7 7 7 7 7 *N/A 42 100% 
Appraiser8 7 7 7 7 7 7 7 *N/A 42 100% 
Appraiser10 7 7 7 7 7 7 7 *N/A 42 100% 
Total 
Domain 3 63 63 63 63 63 62 63 *N/A 377 99.70% 
 
Domain 4: Clarity and Presentation 
Domain 4 Item15 Item16 Item17 Total 
% 
Score           
Appraiser1 7 7 7 21 100%      
Appraiser2 7 7 7 21 100%      
Appraiser3 7 7 7 21 100%      
Appraiser4 7 7 7 21 100%      
Appraiser5 7 7 7 21 100%      
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Appraiser6 7 7 7 21 100%      
Appraiser7 7 7 7 21 100%      
Appraiser8 7 7 7 21 100%      
Appraiser10 7 7 7 21 100%      
Total Domain 
4 63 63 63 189 100%          
 
Domain 5: Applicability 
Domain 5 Item18 Item19 Item20 Item21 Total 
% 
Score         
Appraiser1 6 7 7 *N/A 20 95.2%     
Appraiser2 7 7 7 *N/A 21 100%     
Appraiser3 6 7 7 *N/A 20 95.2%     
Appraiser4 7 7 7 *N/A 21 100%     
Appraiser5 7 7 7 *N/A 21 100%     
Appraiser6 6 7 7 *N/A 20 95.2%     
Appraiser7 7 7 7 *N/A 21 100%     
Appraiser8 7 7 7 *N/A 21 100%     
Appraiser10 6 7 7 *N/A 20 95.2%     
Total Domain 
5 59 63 63  *N/A 185  97.5%         
 
Domain 6: Editorial Independence 
Domain 6 Item22 Item23 Total 
% 
Score             
Appraiser1 7 *N/A 7 100%       
Appraiser2 7 *N/A 7 100%       
Appraiser3 7 *N/A 7 100%       
Appraiser4 7 *N/A 7 100%       
Appraiser5 7 *N/A 7 100%       
Appraiser6 7 *N/A 7 100%       
Appraiser7 7 *N/A 7 100%       
Appraiser8 7 *N/A 7 100%       
Appraiser10 7 *N/A 7 100%       
Total Domain 6 63 N/A 63 100%             
 
Overall Guideline Assessment             
1. Rate the overall quality of this guideline             
      Score Total 
% 
Score           
Appraiser1   7 7 100%      
Appraiser2   7 7 100%      
Appraiser3   7 7 100%      
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Appraiser4   7 7 100%      
Appraiser5   7 7 100%      
Appraiser6   7 7 100%      
Appraiser7   7 7 100%      
Appraiser8   6 7 86%      
Appraiser10   7 7 100%      
Total Score   62 62 98.1%           
 
2. I would recommend this guideline for use             
      Yes Yes, with modification No       
Appraiser1   Yes        
Appraiser2   Yes        
Appraiser3   Yes        
Appraiser4   Yes        
Appraiser5   Yes        
Appraiser6   Yes        
Appraiser7   Yes        
Appraiser8   Yes        
Appraiser10   Yes        
# of Approval     100%               
*All participants recommended and accepted the CPG with 100% approval without modification. 
DISCUSSION 
Ten experts were invited, consented, and participated in this project.  Each participant responded to 
AGREE II items by rating domains and returning valuable expertise feedback within the allotted period.  
Sources of evidence were obtained through a literature scope with a meta-analysis of systematic data 
collection on publications containing meta-analyses of articles. Significant data were obtained scoping the 
literature and incorporation consensus recommendations from a panel of hospice experts.  This 
methodology was imperative in aiding development and finalization of the EBP CPG to form a 
standardized process for frontline hospice practitioners to adequately prescribe strong opioids in hospice 
programs. The CPG developed guideline for hospice patients receiving EOLC is necessary as it allows 
practitioners the ability to manage pain effectively manage pain. Furthermore, it ensures the safety with 
prescribing strong opioids to hospice patients to side effects and adverse events. Moreover, there are 
assurances hospice patients, and their families have been included in the production of the CPG to optimize 
use and success of the guidance. It will also help costs acquisition relevant to policy and societal 
implications of hospice care.  
 
The ACE star model of knowledge translation was the theory selected to link the evidence to practice. The 
model depicts the Cycle of Knowledge Transformation (Melnyk &Fineout-Overholt, 2011). The theoretical 
basis for ACE is dependent upon the knowledge “form” in the five specific transformation stages (Melnyk 
&Fineout-Overholt, 2011). According to Melnyk and Fineout-Overholt (2011), they are: 1.) Knowledge 
discovery, 2.) Evidence summary, 3.) Translation to practice recommendations, 4.) Implementation into 
practice, and 5.) Evaluation. This final step is evaluative and crucial to incorporate patients, providers, and 
systems outcomes to verify the EBP success. The model helped establish the CPG for prescribing strong 
opioids in hospice for EOLC. A formative panel of experts provided explicit feedback with the initial 
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drafted development of the CPG. Based on feedback from the formative review of the guidance, the CPG 
was minimally modified to reflect input obtained from the questionnaire of the appraisal tool. The final 
process, the evaluative stage, consisted of the summative group appraising outcomes with the AGREE II 
instrumentation. As each group contained highly respected and experienced panelist, the CPG was 
developed from a substantial amount of substantive feedback strengthening the CPG’s validity. The 
responses obtained from the formative group confirmed a need for the CPG reinforced with an overall 
100% approval.  
 
Table 5. 
Delivery of an EBP CPG for Safe and Effective Prescribing Opioids for Adult Hospice Patients  
Communication 
 Inquire about concerns when prescribing opioids for pain about concerns for 
instance: 
•Fears treatment imply  
•Side effects  
•Addiction 
•Tolerance  
 Provide written and oral information on treatment to carers and patients on 
strong opioids, with the following: 
• When, What, and Why strong opioids are used for pain management 
•Possibilities of effectiveness  
•Strong opioids for breakthrough and background pain, addressing: 
•How, when, and how often to take strong opioids  
•Duration of pain relief should last 
•Side effects and signs of toxicity  
•Proper storage  
• Further prescribing and Follow-up and  
•After hours information, especially with treatment initiation  
 Patient accessibility to frequent review of side effects and pain management 
________________________________________________________________
__ 
Starting Strong Opioids-Dose Titration 
 With treatment initiation of strong opioids, offer oral immediate or sustained-
release (consideration to patient’s choice) 
 Oral Morphine immediate-release rescue doses with breakthrough pain. 
 Careful titration with Comorbidities 
 Adjust the dosage until optimal balance exists between side effects and 
acceptable pain control goals.  If unable to reach balance after adjusting the 
dose a few, seek out a specialist advice. Do frequent patient reviews in the 
titration phase. 
 Obtain specialist advice prior to prescribing strong opioids for patients having 
moderate or severe liver or renal impairments. 
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 ________________________________________________________________
__ 
 First-line Maintenance Treatments 
 Oral, sustained-release morphine 
 Avoid frequent prescribing of transdermal patch forms if the oral route is 
available 
 If pain is uncontrolled persistently, despite optimizing first-line maintenance 
dosing, consider specialist advice and review analgesic plan. 
 
Table 6. 
Delivery of an EBP CPG for Safe and Effective Prescribing Opioids for Adult Hospice 
Patients-Additional Information and Optional Alternative Treatments 
 __________________________________________________________________ 
First-line Treatment with Transdermal Patches-if Opioids May Not Be given by Mouth 
 Initiation of transdermal patches are considered with the lowest acquisition 
patient cost when the oral route may not be given, stable analgesic 
requirements are stable, and specialist advice when needed. 
 Caution opioid equivalence for transdermal patches calculations 
________________________________________________________________
__ 
First-line Treatments with Subcutaneous Delivery-if Oral Opioids Are Not an Option  
 Consider to subcutaneous opioids initiation with cost acquisition 
 ________________________________________________________________
__ 
First-line Treatments for Breakthrough Pain- If the Oral Route is Unavailable with 
Opioids 
 If pain remains inadequately controlled despite optimizing treatment, consider 
seeking specialist advice. 
 ________________________________________________________________
__ 
 Management of Constipation 
 Inform patients opioid-induced constipation affects many patients with strong 
opioid treatments. 
 Prescribe laxatives (regularly at effective doses) when beginning strong opioid 
treatment 
 Inform patients constipation treatment takes time and adherence is essential. 
 Optimize laxative treatments for constipation prior to switching to strong 
opioids. 
 ________________________________________________________________
__ 
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 Management of Nausea 
 Advise patients nausea is possible when initiating strong opioids or with dose 
increases and it is likely transient. 
 With persistent nausea, prescribe and optimize anti-emetics prior to 
consideration of switching strong opioids. 
 ________________________________________________________________
__ 
 Management of Drowsiness 
 Advise patients mild drowsiness or impaired concentration might happen when 
strong opioids are initiated or with dosage increase, and is often transient. 
Warn patients impaired concentration might affect their driving ability and 
undertaking any other manual tasks. 
 With patients having persistent or moderate-to-severe central nervous system 
side effects: 
•For uncontrolled pain, consider dosage reduction  
• For uncontrolled pain, consider switching opioids 
• For pain remains uncontrolled despite optimizing treatment, consider 
specialist advice. 
 ________________________________________________________________
__ 
 Clinical Algorithm(s)  
 A full version of this original CPG includes a care pathway document for 
patients requiring strong opioids for pain management (step 3 of WHO pain 
ladder).  
 
 
ANALYSIS OF SELF 
From a self-reflective view, development of the Capstone allowed personal and professional enrichment from the 
ensuing integration scholarship and application of transdisciplinary doctoral competencies. I have become consumed 
with interactive engagements of rigors and nuances, which strengthened my intellectual abilities to positively apply my 
scholarly plateau of knowledge to the greater good of society. As a practitioner, I feel this theoretical engagement with 
science has prepared me at the highest level of leadership and doctoral clinical practice. As a project developer, I have 
reaped relevant benefits from an intellectual novel use of my curiosity by exploring innovative ways to address opioid 
use. This experiential and pragmatic project has been a most outstanding assignment to display an achievement. The 
Capstone has suitably brought appropriate closure to my doctoral graduate experiences. 
CONCLUSIONS AND SUMMARY 
The CPG for hospice patients provides standardized processes for frontline practitioners to prescribe strong opioids 
with EOLC effectively.  Establishing an EBP CPG for EOLC with terminally ill patients standardizes processes for 
frontline practitioners to have consistency when prescribing stop opioids in hospice programs. The CPC on strong 
opioids has potential widespread success for several reasons, the EBP CPG: (a) ensure safe prescribing, (b) maximizes 
the effectiveness of opioids (c) allows for sufficient communication between patients and providers(d) diminishes the 
likelihood of uncontrolled pain episodes (e) and offers alternatives with strong opioids prescribing for pain 
management based on specific clinical circumstances with EOLC.  The CPG is concise, but comprehensive, covers key 
content areas, is comprehensive, captures the current clinical state of hospice, meets the stated objectives and goals, and 
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is appropriate for hospice settings. The CPG addresses all stated objectives and AGREE II domains, as it is a crucial 
aspect of EOLC in hospices. The CPG promotes safety in working with hospice patients and EOLC. The CPG benefits 
practitioners from a broader social action process for communities, individuals, and the organization. The CPG may 
benefit the organization as well as influence a social-political change. The impetus for social change lies within the 
context of practitioners gaining mastery with adequate opioid prescribing to address national and global concerns with 
pain management issues. The agency may be a facilitator of implementing the CPG in an environment that improves 
equity and QOL for adult hospice patients with unmanaged pain. Additionally, frontline practitioners have guidance to 
optimize achieving adequate pain management, which leads to improved QOL and EOLC outcomes globally. 
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Appendix A: Walden IRB Site Approval Form for QI Doctoral Project and Disclosure to 
Expert Panelist Form for Anonymous Questionnaires 
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Appendix B: Deyta Survey Questionnaire: Hospice Services Inventory 
 Deyta Survey Questionnaire: Hospice Services Inventory Yes No 
1. While under hospice care, did the patient have pain?    
2. While receiving hospice care did they get prescriptions for pain?   
3. When receiving hospice services did patient take any prescribed drugs 
for pain? 
  
4. Did the patient have enough medicine for their pain?   
5. Did the staff provide education to address medication concerns?   
6. Did you or the family receive any education al information from the 
hospice team about medications used to manage the patient’s pain? 
  
7. Did you want more information than what you got about medicines used 
to manage the patient’ pain? 
  
8. As far as you know, did any member of the hospice team speak to the 
patient/family about medications? 
  
9. Did the hospice team explain medications in a way you could 
understand? 
  
10. Did the caregiver, receive enough instruction to take care of the patient?   
11. Were you confident you knew what to expect with medications given to 
treat pain? 
  
12. Were you confident you knew as much as you needed to know about 
medicines used to manage the patient’s pain? 
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Appendix C: Medicare COPS, QAPI, and Missoula VITAS QOL Index 
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Appendix D: Instructions for the Review of the AGREE II Guideline and Rating Scale 
Instructions: Please evaluate the guideline utilizing the AGREE II instrument and 
offer suggestions to enhance development of the guideline.   
1. Changes may be applied to the guideline, AGREE II tool, or by comments. 
2. Please provide a rationale with any modifications suggested. 
3. Please return evaluations today or no later than 14 days.  
4. If clarification is desired, please contact me via intranet email or in person.  
Explicit scope 
and purpose 
Overall objective(s), clinical questions, and target population is 
explicated 
Stakeholder 
involvement 
Patient(s) are involved in guideline development and all audiences 
are defined clearly and involved in pilot-testing.  
Rigor  Recommendations are linked explicitly to supporting evidence and 
there is discussion of health benefits or risks. 
Development Recommendations are reviewed externally before publication and 
development group provides details of updating. 
Clarity of 
presentation 
Recommendations are not ambiguous and do consider different 
possible options; key recommendations are easily identified; and a 
summary document and patient education materials are provided.  
Applicability Organizational changes, cost implications of applying 
recommendations and review criteria for monitoring guidelines use 
are explicated.  
Personal 
Declaration  
Views or interests have not influenced final recommendations; 
members of the guideline group have declared possible conflicts of 
interest. 
Additional 
Suggestions 
Modifications or Comments 
 
Rating Scale 
 
Each AGREE II item and the two global rating items are rated on a 7-point scale (1-strongly 
disagree to 7-strongly agree). All items are rated on the following 7-point scale: 
1 
Strongly Disagree 
2 3 4 5 6 7 
Strongly Agree 
Score of 1 (Strongly Disagree). A score of 1 should be given when there is no information that is relevant to 
the AGREE II item or if the concept is very poorly reported. Scores 2- 6. A score between 2 and 6 is assigned 
when the reporting of the AGREE II item does not meet the full criteria or considerations. A score is assigned 
depending on the completeness and quality of reporting. Scores increase as more criteria are met and 
considerations addressed. The “How to Rate” section for each item includes details about assessment criteria 
and considerations specific to items. Score of 7 (Strongly Agree). 7 should be given with exceptional quality 
reporting. 
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Appendix E: AGREE II DOMAINS 
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Appendix F: Resources 
Accreditation Commission for Health Care (ACHC) 
Deyta Expert satisfaction surveys  
Dr. Patrick Albert Palmieri Scholar Focused On Global Nursing 
Scholarship (DNP Committee/*URR) 
Dr. Deborah (Deb) Lewis, (DNP Committee Member/URR) 
Dr. Marisa L. Wilson DNSc, MHSc, RN-BC, CPHIMS (DNP 
Committee) 
Dr. Murielle Beene, (DNP Committee Member) 
The Joint Commission (TJC) 
John Hopkins Levels of Evidence Hierarchy  
Medicare Conditions of Participation (COPS) 
Missoula VITAS Quality of Life Index 
National Academy of Sciences 
National Hospice and Palliative Care Organization (NHPCO)  
NHPCO Quality Partners Initiatives 
National Quality Forum [NQF] 
Outcome Concept Systems (OCS) 
Quality Assurance (QA) and Performance Improvement (PI) 
Robert J. Woods Foundation (RJWF)  
Samuel(S) Herrington 
 
